Any dementia, excluding more controls

KRA_PSY_DEMENTIA_EXMORE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00-F09, F05.1, G30 Hospital discharge: ICD-9 — 290\|2912A\|2828C\|2941A\|3310A\|3311A\|4378A Hospital discharge: ICD-8 — 290 Cause of death: ICD-10 — F00-F09, F05.1, G30 Cause of death: ICD-9 — 290\|2912A\|2828C\|2941A\|3310A\|3311A\|4378A Cause of death: ICD-8 — 290 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF9

NAME	KRA_PSY_DEMENTIA_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F0[0-3]\|F051\|G30
HD_ICD_9	290\|2912A\|2828C\|2941A\|3310A\|3311A\|4378A
HD_ICD_8	290
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F0[0-3]\|F051\|G30
COD_ICD_9	290\|2912A\|2828C\|2941A\|3310A\|3311A\|4378A
COD_ICD_8	290
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Any dementia, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	385404	236885	144096
Only index persons	275980	173824	102156
Unadjusted period prevalence (%)
Whole population	5.73	6.79	4.03
Only index persons	5.47	6.39	3.90
Median age at first event (years)
Whole population	81.77	82.80	80.17
Only index persons	82.36	83.39	80.60

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	21782	9844	11938
Unadjusted period prevalence (%)	4.40	3.36	5.26
Median age at first event (years)	79.82	80.21	79.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7203: Matched controls
63145

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1AD

NOMESCO Finland

CT of head and brain

3.1

323.0

2822

10955

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

5.6

323.0

1326

2437

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

111.6

323.0

1201

113

N06DA04

ATC

galantamine; oral

28.1

323.0

692

238

N06DA02

ATC

donepezil; oral

52.3

323.0

2787

752

SPAT1053

SPAT

Memory test

4.8

323.0

3140

8726

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

29.4

323.0

636

207

N03AG01

ATC

valproic acid; systemic, rectal

11.5

323.0

715

600

SPAT1216

SPAT

Assessment of functional ability

3.5

323.0

2204

6991

N05BA04

ATC

oxazepam; oral

3.4

323.0

2097

6739

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

141.8

323.0

1213

N05AH03

ATC

olanzapine; systemic

49.2

323.0

556

107

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

323.0

1997

6446

P20

ICPC

Memory disturbance

10.0

323.0

3384

5138

TAB00

NOMESCO Finland

Lumbar puncture

9.2

323.0

778

822

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

37.2

323.0

657

170

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

47.3

323.0

1123

245

G30.1

ICD-10 Finland

Alzheimer disease with late onset

73.5

323.0

2644

495

R53

ICD-10 Finland

Malaise and fatigue

3.6

323.0

2123

6561

P70

ICPC

Dementia

28.2

323.0

637

216

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

11.8

323.0

2251

2349

N06DX01

ATC

memantine; oral

64.5

323.0

3020

698

G30.0

ICD-10 Finland

Alzheimer disease with early onset

460.0

323.0

537

A28

ICPC

Limited function/disability NOS

4.9

323.0

2486

6153

SPAT1234

SPAT

Support of social functional capacity

7.2

323.0

868

1174

F06.7

ICD-10 Finland

Mild cognitive disorder

10.1

323.0

695

662

SPAT1245

SPAT

Provision of support and information to patient’s family members

7.2

323.0

896

1219

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

83.6

323.0

555

F32.9

ICD-10 Finland

Depressive episode, unspecified

14.8

323.0

770

506

G30.8

ICD-10 Finland

Other Alzheimer disease

59.5

323.0

788

130

F03

ICD-10 Finland

Unspecified dementia

72.3

323.0

1740

277

N05AH04

ATC

quetiapine; oral

12.3

323.0

1797

1655

N05AX08

ATC

risperidone; systemic

46.9

323.0

1599

381

G30

ICD-10 Finland

Alzheimer disease

54.9

323.0

414

N06AX11

ATC

mirtazapine; oral

3.2

323.0

2594

9434

N06DA03

ATC

rivastigmine; oral, transdermal

50.5

323.0

1743

396

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

29.4

323.0

469

149

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

6.2

318.3

954

1520

R41.3

ICD-10 Finland

Other amnesia

9.1

292.6

667

701

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.7

284.2

2805

12200

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

82.2

281.2

331

N06AB10

ATC

escitalopram; oral

4.1

276.9

1255

3106

F01.9

ICD-10 Finland

Vascular dementia, unspecified

57.8

274.9

340

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

273.4

1864

6381

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

193.8

273.1

297

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

264.2

269.6

288

R41.0

ICD-10 Finland

Disorientation, unspecified

10.6

268.0

559

497

N06AB04

ATC

citalopram; systemic

3.3

263.1

1587

4952

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

68.3

253.6

306

XA800

NOMESCO Finland

Neuropsychological investigation

8.3

243.3

585

667

SPAT1254

SPAT

Administration of medicine

3.0

231.7

1581

5329

L28

ICPC

Limited function/disability (L)

2.8

227.4

1800

6677

F29

ICD-10 Finland

Unspecified nonorganic psychosis

190.9

213.0

232

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

209.9

1359

4385

N05BA06

ATC

lorazepam; systemic, sublingual

6.9

208.2

566

773

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

5.6

198.8

637

1077

F05.1

ICD-10 Finland

Delirium superimposed on dementia

605.6

195.0

202

N06AX26

ATC

vortioxetine; oral

9.5

190.7

419

406

A06AD11

ATC

lactulose; oral

2.8

184.0

1401

4986

N05AD01

ATC

haloperidol; systemic

12.0

182.5

356

273

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.7

182.3

892

2302

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

179.4

2136

9707

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

19.6

178.9

286

133

G40.9

ICD-10 Finland

Epilepsy, unspecified

7.1

176.3

464

602

F05.9

ICD-10 Finland

Delirium, unspecified

13.4

175.9

326

223

N06AX16

ATC

venlafaxine; oral

4.1

173.4

749

1727

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

133.6

172.5

193

N05AA02

ATC

levomepromazine; systemic

13.6

165.8

305

205

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

757.0

163.9

169

A04

ICPC

Weakness/tiredness general

2.8

163.7

1230

4309

G20

ICD-10 Finland

Parkinson disease

5.0

160.1

559

1036

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

38.2

159.0

212

T36

ICD-10 Finland

Poisoning by systemic antibiotics

21.2

158.1

246

105

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.7

154.4

577

1149

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

+∞

152.0

153

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

5.4

152.0

500

865

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.9

149.1

689

1679

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.9

149.0

688

1675

N06AB06

ATC

sertraline; oral

4.2

148.6

623

1389

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

69.6

148.0

178

N05AB03

ATC

perphenazine; systemic, rectal

16.8

146.6

247

133

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.2

146.6

861

2540

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

674.5

146.1

151

SPAT1229

SPAT

Assessment of need for aid

3.0

144.2

948

3026

WYA20

NOMESCO Finland

Home visit

13.8

143.7

262

172

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.3

142.3

473

827

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

52.7

140.3

176

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

108.9

138.6

158

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

44.1

136.7

177

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.1

136.1

403

611

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

615.1

133.2

138

N05AX12

ATC

aripiprazole; systemic

162.0

131.6

145

F22.0

ICD-10 Finland

Delusional disorder

83.9

127.9

150

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

127.1

1216

4828

SPAT1172

SPAT

Guidance concerning hydration

6.6

126.4

351

488

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

126.1

127

N04AA02

ATC

biperiden; systemic

35.6

123.5

167

U04

ICPC

Incontinence urine

3.7

119.4

580

1465

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

280.8

119.2

127

F20.9

ICD-10 Finland

Schizophrenia, unspecified

+∞

119.1

120

N05AN01

ATC

lithium; oral

39.6

117.3

155

F10.20

ICD-10 Finland

Alcohol dependence currently independent

73.1

116.5

139

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

114.9

1210

5019

S01.0

ICD-10 Finland

Open wound of scalp

3.1

114.6

698

2093

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

8.0

112.4

272

308

S06.0

ICD-10 Finland

Concussion

2.9

111.5

784

2588

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

7.9

111.3

271

310

F10.25

ICD-10 Finland

Alcohol dependence continuous use

109.6

108.0

123

I95.1

ICD-10 Finland

Orthostatic hypotension

4.2

107.8

444

966

N03AE01

ATC

clonazepam; systemic

3.8

106.6

503

1237

S72.0

ICD-10 Finland

Fracture of neck of femur

4.4

105.0

414

863

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

9.4

105.0

230

220

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

10.1

104.4

220

196

G31.0

ICD-10 Finland

Circumscribed brain atrophy

25.3

102.0

150

N05BA01

ATC

diazepam; systemic, rectal

2.5

102.0

924

3528

N05AH02

ATC

clozapine; systemic

469.8

101.5

106

F10.09

ICD-10 Finland

Alcohol intoxication UNS

142.4

100.7

112

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

99.3

1204

17615

N06AX21

ATC

duloxetine; oral

3.0

99.1

647

2028

SPAT1301

SPAT

No procedures

1.8

99.0

2697

16040

109

Kela drug reimbursment

Multiple sclerosis

20.9

98.9

154

N87

ICPC

Parkinsonism

6.5

98.8

275

383

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

98.3

1184

5195

W19

ICD-10 Finland

Unspecified fall

2.6

98.0

792

2832

G35

ICD-10 Finland

Multiple sclerosis

11.0

96.8

195

159

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

121.2

96.7

109

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

8.4

96.7

226

242

P29

ICPC

Psychological sympt/compl other

6.4

96.5

272

385

N05AF03

ATC

chlorprothixene; systemic

28.4

96.2

137

R55

ICD-10 Finland

Syncope and collapse

2.3

96.1

1035

4303

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

95.2

N03AX09

ATC

lamotrigine; oral

7.8

94.9

232

267

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

94.2

1506

7424

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.6

92.8

346

681

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

75.3

92.7

110

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

842.5

92.3

F34.1

ICD-10 Finland

Dysthymia

20.6

91.5

143

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

415.5

89.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

89.5

998

4211

N02AA05

ATC

oxycodone; systemic

2.0

88.5

1284

6075

N05CD07

ATC

temazepam; oral

2.3

88.4

899

3626

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

111.0

88.0

100

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

26.9

88.0

127

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

5.8

85.3

258

400

F99

ICD-10 Finland

Mental disorder, not otherwise specified

165.1

84.7

SPAT1252

SPAT

Overall medication plan or its review

2.5

84.1

720

2650

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

9.2

83.7

185

180

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

264.9

83.3

IGY02

NOMESCO Finland

Psychiatric monitoring contact

105.4

83.2

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

82.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

30.7

81.8

114

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

159.7

81.7

SPAT1360

SPAT

Extensive global examination

2.4

81.5

766

2960

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

81.3

SPAT1101

SPAT

Orthostatic test

2.9

80.6

545

1740

A29

ICPC

General symptom/complaint other

2.2

79.5

977

4291

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

79.4

953

4140

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

79.1

643

2295

R42

ICD-10 Finland

Dizziness and giddiness

1.8

79.0

1795

9921

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

5.7

78.8

241

379

N04BD01

ATC

selegiline; oral

5.9

78.7

236

362

C03CA01

ATC

furosemide; systemic

1.7

77.2

2426

14748

SPAT1304

SPAT

Counselling and guidance related to ageing

2.2

77.0

849

3545

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

18.3

77.0

125

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

6.9

76.8

203

263

N05AC02

ATC

thioridazine; oral

20.8

76.5

119

SPAT1246

SPAT

Screening of depression or other psychiatric problem

5.1

75.0

255

454

N30.0

ICD-10 Finland

Acute cystitis

2.0

74.9

1048

4852

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

34.5

74.5

101

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.8

74.5

267

504

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

179.4

74.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

73.9

398

1083

P99

ICPC

Psychological disorders other

14.7

73.4

129

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.5

72.9

230

376

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

72.5

610

2214

N06AB03

ATC

fluoxetine; oral

2.4

72.2

679

2618

N03AX14

ATC

levetiracetam; systemic

4.4

72.0

279

570

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.5

71.9

199

275

F21

ICPC

12.1

71.5

137

101

N05CF01

ATC

zopiclone; oral

1.7

71.2

2164

12961

F10.24

ICD-10 Finland

Alcohol depence active use

46.9

70.7

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

70.4

638

2412

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

70.4

499

1639

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

636.0

69.6

SPAT1167

SPAT

Insertion of urinary catheter

3.2

69.2

391

1102

F00

ICD-10 Finland

Dementia in Alzheimer disease

37.1

69.0

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.4

68.5

220

367

P15

ICPC

Chronic alcohol abuse

10.1

68.4

143

126

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

166.0

68.4

F01.2

ICD-10 Finland

Subcortical vascular dementia

26.4

67.7

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

+∞

67.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

67.2

753

3155

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

66.4

N06AX12

ATC

bupropion; oral

6.8

66.2

176

230

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

307.5

66.1

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

24.3

64.9

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

591.3

64.6

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

298.5

64.1

P76

ICPC

Depressive disorder

4.8

63.8

227

425

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.4

63.4

335

897

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

573.4

62.7

N03AF02

ATC

oxcarbazepine; oral

4.1

62.2

263

584

P03

ICPC

Feeling depressed

3.4

61.8

322

853

N02BE01

ATC

paracetamol; systemic, rectal

1.8

61.8

6229

49491

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

564.5

61.7

L03AB07

ATC

interferon beta-1a; parenteral

31.4

61.5

N05AF05

ATC

zuclopenthixol; systemic

194.5

60.8

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

60.5

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

101.7

60.4

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

101.7

60.4

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

78.6

60.3

E86

ICD-10 Finland

Volume depletion

4.5

60.3

226

447

R33

ICD-10 Finland

Retention of urine

2.1

60.3

733

3179

AXX01

SPAT

4.9

60.1

211

390

P72

ICPC

Schizophrenia

54.6

59.7

N06AX03

ATC

mianserin; oral

3.5

59.6

300

774

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

59.5

708

3039

N04BD02

ATC

rasagiline; oral

7.3

59.0

150

184

F32.1

ICD-10 Finland

Moderate depressive episode

7.7

59.0

144

166

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

21.9

58.4

F01

ICD-10 Finland

Vascular dementia

25.1

58.1

G04BD12

ATC

mirabegron; oral

1.9

58.0

1023

5127

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

185.6

57.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

57.0

57.7

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

528.8

57.7

F0019, G301

ICD-10 Finland

+∞

57.5

F05.8

ICD-10 Finland

Other delirium

12.7

57.3

107

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

271.5

57.3

F41.1

ICD-10 Finland

Generalized anxiety disorder

10.3

57.1

118

102

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

24.0

56.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

56.2

618

2560

N05BE01

ATC

buspirone; oral

6.0

55.7

162

240

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

+∞

55.5

F32

ICD-10 Finland

Depressive episode

4.3

55.5

217

448

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

55.1

941

4656

N05AA01

ATC

chlorpromazine; systemic, rectal

54.6

55.0

N29

ICPC

Neurological sympt/complt other

4.2

54.7

222

475

R11

ICD-10 Finland

Nausea and vomiting

2.3

54.5

550

2184

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

54.4

858

4121

N86

ICPC

Multiple sclerosis

13.3

54.2

SPAT1240

SPAT

Therapeutic discussion

2.6

54.2

418

1440

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.3

53.9

567

2298

N03AF01

ATC

carbamazepine; oral, rectal

2.8

53.6

373

1206

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

53.5

F31.8

ICD-10 Finland

Other bipolar affective disorders

253.0

53.3

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

53.2

612

2583

L03AX13

ATC

glatiramer acetate; parenteral

40.7

52.9

188

Kela drug reimbursment

Psychosis requiring demanding treatment

+∞

52.5

N07BB01

ATC

disulfiram; oral

5.1

52.2

176

311

F60.9

ICD-10 Finland

Personality disorder, unspecified

475.2

51.8

F009, G309

ICD-10 Finland

475.2

51.8

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

51.5

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

51.5

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

8.0

50.9

121

134

Z75.5

ICD-10 Finland

Holiday relief care

15.9

50.7

193

Kela drug reimbursment

Rasagiline

7.6

50.2

123

143

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

457.4

49.8

SPAT1307

SPAT

Psychosocial counselling and guidance

4.0

49.5

211

473

F61.0

ICD-10 Finland

Mixed personality disorders

234.5

49.4

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

49.3

771

3686

S70.0

ICD-10 Finland

Contusion of hip

3.1

49.2

291

846

G72.8

ICD-10 Finland

Other specified myopathies

6.0

49.0

143

213

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

73.2

49.0

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

48.5

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

48.5

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

48.1

475

1866

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

47.3

794

3891

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

152.9

47.2

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

116.9

47.1

N05AD03

ATC

melperone; systemic

18.4

46.7

N06AA09

ATC

amitriptyline; systemic

2.0

46.6

656

3009

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

46.6

SPAT1139

SPAT

Nutrition survey

3.0

46.4

283

841

N04BC04

ATC

ropinirole; oral

4.8

46.3

163

303

IGY99

NOMESCO Finland

Other psychiatric treatment contact

61.9

46.2

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

79.5

46.1

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

46.0

2401

15966

P28

ICPC

Limited function/disability (P)

34.2

45.9

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

45.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

45.2

356

1239

R1250

NOMESCO Finland

Evaluation of functional capability

4.3

44.8

176

366

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

23.3

44.4

J01EA01

ATC

trimethoprim; systemic

1.5

43.9

1629

10027

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

43.6

P01

ICPC

Feeling anxious/nervous/tense

2.9

43.3

280

865

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.3

43.2

170

354

N06AG02

ATC

moclobemide; oral

3.0

43.2

270

816

N30.9

ICD-10 Finland

Cystitis, unspecified

2.4

43.0

394

1489

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

44.1

43.0

SPAT1262

SPAT

Handing over of treatment supplies

1.6

43.0

1495

9053

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

42.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

8.5

42.5

101

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

57.3

42.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

42.5

1151

6533

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

42.4

504

2152

N28

ICPC

Limited function/disability (N)

4.1

42.3

173

374

AA400

NOMESCO Finland

Electroconvulsive therapy

386.1

42.0

N99

ICPC

Neurological disease other

5.1

41.5

138

241

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

41.5

1146

6533

A10AE04

ATC

insulin glargine; parenteral

1.9

41.4

693

3384

SPAT1263

SPAT

Sampling

1.4

41.4

2992

21080

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

41.1

1137

6485

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

41.0

369

1380

F01.0

ICD-10 Finland

Vascular dementia of acute onset

377.2

41.0

M03BX01

ATC

baclofen; systemic

4.7

40.5

144

271

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

4.8

40.4

141

260

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.0

40.3

572

2627

N05BA12

ATC

alprazolam; oral

2.0

39.6

523

2331

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

39.6

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

15.0

39.4

C10AA01

ATC

simvastatin; oral

1.4

39.2

3831

28381

183

Kela drug reimbursment

Lamotrigin and topiramate

11.2

39.2

Z29

ICPC

Social problem NOS

4.8

38.9

135

248

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

185.0

38.7

G40

ICD-10 Finland

Epilepsy

7.1

38.7

124

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

+∞

38.6

K59.0

ICD-10 Finland

Constipation

2.2

38.3

406

1647

SPAT1279

SPAT

Preparation of immediate hospitalisation

5.9

38.2

112

169

J01CA08

ATC

pivmecillinam; oral

1.4

38.0

2246

15166

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

180.6

37.7

N17

ICPC

Vertigo/dizziness

1.7

37.7

884

4806

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

37.6

N05AL01

ATC

sulpiride; systemic

6.8

37.6

129

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

37.5

1195

7051

R32

ICD-10 Finland

Unspecified urinary incontinence

2.9

37.5

249

781

K90

ICPC

Stroke/cerebrovascular accident

2.7

37.4

275

921

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

5.0

37.4

126

224

N05BA02

ATC

chlordiazepoxide; systemic

4.7

37.2

134

256

R25.1

ICD-10 Finland

Tremor, unspecified

2.8

37.1

256

824

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

56.6

36.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

36.7

1163

6847

A01

ICPC

Pain general/multiple sites

2.0

36.7

526

2423

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

36.6

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

75.8

36.6

N04BX02

ATC

entacapone; oral

11.4

36.6

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

36.4

259

848

S00.0

ICD-10 Finland

Superficial injury of scalp

3.7

36.3

169

410

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

36.1

486

2185

S06.3

ICD-10 Finland

Focal brain injury

4.9

35.6

122

221

N06AA12

ATC

doxepin; systemic

2.4

35.5

313

1157

N06AX05

ATC

trazodone; oral

5.1

35.0

115

199

N06AB05

ATC

paroxetine; oral

2.7

35.0

255

849

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

34.8

2195

14947

164

Kela drug reimbursment

Fingolimod

72.3

34.7

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

34.7

R44.1

ICD-10 Finland

Visual hallucinations

10.1

34.5

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.4

34.3

130

262

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

28.2

34.2

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

315.0

34.1

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

315.0

34.1

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.7

34.1

157

378

F31

ICD-10 Finland

Bipolar affective disorder

52.9

34.0

F0009, G300

ICD-10 Finland

+∞

33.7

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

33.6

492

2283

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

33.4

996

5765

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.9

33.1

143

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

+∞

32.7

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.2

32.5

129

272

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

32.4

584

2915

N03AX18

ATC

lacosamide; systemic

8.7

32.3

R44.3

ICD-10 Finland

Hallucinations, unspecified

14.5

32.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

32.1

1777

11768

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

22.3

32.0

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.6

32.0

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.0

31.9

104

F43.29

ICD-10 Finland

Adaptation disorder UNS

14.1

31.8

353

Kela drug reimbursment

Cladribine and fingolimod

81.5

31.8

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

31.6

271

989

SPAT1243

SPAT

Psychiatric/psychological examination

6.6

31.6

112

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

31.5

1673

10982

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

31.4

272

998

F39

ICD-10 Finland

Unspecified mood [affective] disorder

27.7

31.2

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

288.3

31.2

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

31.1

1590

10359

Z72.1

ICD-10 Finland

Alcohol use

9.0

31.0

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

15.1

31.0

N19

ICPC

Speech disorder

4.1

30.9

127

277

130

Kela drug reimbursment

Malignant tumour

0.5

30.9

222

3950

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

79.3

30.9

G04BD04

ATC

oxybutynin; oral, transdermal

2.0

30.9

400

1767

F20.5

ICD-10 Finland

Residual schizophrenia

+∞

30.7

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

30.7

L03AB08

ATC

interferon beta-1b; parenteral

30.8

30.6

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

30.4

637

3334

G04BD08

ATC

solifenacin; oral

1.8

30.3

564

2844

F32.8

ICD-10 Finland

Other depressive episodes

15.5

30.1

N88

ICPC

Epilepsy

9.0

30.1

SPAT1125

SPAT

Stoma care and guidance

3.3

29.9

158

426

N04BC05

ATC

pramipexole; oral

1.8

29.8

554

2793

K08.3

ICD-10 Finland

Retained dental root

1.9

29.8

468

2227

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

+∞

29.7

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

29.7

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

29.7

N05AF01

ATC

flupentixol; systemic

4.9

29.3

178

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.1

29.0

119

260

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

+∞

28.7

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

28.7

F02.89*E03.9

ICD-10 Finland

Dementia in hypothyroidism, acquired

+∞

28.7

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

28.7

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.8

28.6

126

293

H02AB02

ATC

dexamethasone; systemic

0.5

28.6

276

4488

N06AA06

ATC

trimipramine; systemic

3.6

28.4

136

340

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

51.3

28.3

F001, G301

ICD-10 Finland

51.3

28.3

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

28.2

284

1124

K91

ICPC

Cerebrovascular disease

3.5

28.1

138

352

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

136.4

28.1

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

36.2

28.0

Z03

ICPC

Housing/neighbourhood problem

10.5

27.9

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

27.7

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

+∞

27.7

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

+∞

27.7

H46

ICD-10 Finland

Optic neuritis

7.1

27.7

N04BB01

ATC

amantadine; oral

3.3

27.7

147

398

R35

ICD-10 Finland

Polyuria

1.8

27.3

496

2481

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

256.6

27.3

SPAT1251

SPAT

Organisation of medication

2.3

27.2

254

969

SPAT1138

SPAT

Guidance concerning bowel function

3.7

27.2

125

302

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.3

27.1

106

Y94.0

ICD-10 Finland

Accident at home

3.2

27.1

150

419

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

27.1

408

1912

SPAT1260

SPAT

Consultation of another employee

1.4

26.9

1290

8265

N18

ICPC

Paralysis/weakness

2.8

26.9

176

550

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

26.7

29580

ICD-8 Finland

Schizophrenia, Other

+∞

26.7

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

8.0

26.6

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.8

26.6

183

590

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

26.6

404

1899

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

26.5

1128

7053

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.9

26.4

170

526

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.7

26.4

189

624

D21

ICPC

Swallowing problem

3.5

26.3

128

324

F0014, G301

ICD-10 Finland

247.4

26.3

H02AA02

ATC

fludrocortisone; oral

5.6

26.2

125

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

26.2

515

2641

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.5

26.1

125

313

K92.0

ICD-10 Finland

Haematemesis

3.0

26.0

154

451

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

+∞

25.7

F20.0

ICD-10 Finland

Paranoid schizophrenia

+∞

25.7

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.3

25.7

135

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

10.5

25.4

IGV01

NOMESCO Finland

Psychiatric network contact

238.3

25.3

Z51.5

ICD-10 Finland

Palliative care

1.8

25.3

502

2584

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

66.1

25.2

E87.6

ICD-10 Finland

Hypokalaemia

2.4

25.1

218

803

Z28

ICPC

Limited function/disability (Z)

9.2

25.1

N03AB02

ATC

phenytoin; systemic

4.3

25.0

194

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

17.6

24.9

F00, F03

ICD-10 Finland

+∞

24.8

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

24.8

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

24.8

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

24.8

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

24.7

421

2061

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

29.9

24.7

N06AA04

ATC

clomipramine; systemic

4.6

24.7

172

A10BB01

ATC

glibenclamide; oral

2.1

24.6

293

1252

D12

ICPC

Constipation

2.2

24.6

262

1066

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

24.6

244

960

F41.09

ICD-10 Finland

UNS Panic Syndrome

6.2

24.5

P16

ICPC

Acute alcohol abuse

7.4

24.4

W06

ICD-10 Finland

Fall involving bed

5.5

24.4

118

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

24.3

745

4319

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

118.7

24.2

IGP01

NOMESCO Finland

Psychiatric family contact

82.1

24.2

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

24.0

519

2738

EBA30

NOMESCO Finland

Excision of root of tooth

1.9

23.9

365

1719

UKC02

NOMESCO Finland

Cystoscopy

1.4

23.9

1291

8442

SPAT1127

SPAT

Enema

4.8

23.9

151

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

23.8

2361

17040

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.6

23.8

29530

ICD-8 Finland

Schizophrenia, Paranoid type

+∞

23.8

P98

ICPC

Psychosis NOS/other

+∞

23.8

RT250

NOMESCO Finland

+∞

23.8

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

23.8

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

+∞

23.8

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

10.1

23.5

L04AA27

ATC

fingolimod; oral

51.0

23.5

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

23.5

2115

15046

N03AX16

ATC

pregabalin; oral

1.4

23.4

1409

9392

A10AE05

ATC

insulin detemir; parenteral

1.9

23.3

356

1676

A27

ICPC

Fear of other disease NOS

2.0

23.3

324

1474

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

114.3

23.3

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

23.2

314

1412

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

23.2

504

2663

F06.0

ICD-10 Finland

Organic hallucinosis

23.0

23.1

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

23.0

23.1

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

11.0

23.1

R1250

SPAT

5.9

23.1

A46

ICD-10 Finland

Erysipelas

1.5

23.1

963

5983

G91.0

ICD-10 Finland

Communicating hydrocephalus

6.2

22.9

F40.1

ICD-10 Finland

Social phobias

15.9

22.9

N05BA09

ATC

clobazam; oral

11.8

22.9

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.2

22.9

123

338

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

42.5

22.8

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

22.8

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

+∞

22.8

30088

ICD-8 Finland

Neuroses, Other

+∞

22.8

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

22.8

SPAT1050

SPAT

Extensive neurological examination

2.5

22.6

182

644

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

22.5

1903

13389

F80.1

ICD-10 Finland

Expressive language disorder

17.6

22.5

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

22.5

540

2936

N27

ICPC

Fear of neurological disease other

3.0

22.5

134

395

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

59.3

22.4

F01.1

ICD-10 Finland

Multi-infarct dementia

210.9

22.4

N06AB08

ATC

fluvoxamine; oral

3.1

22.3

129

373

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

109.9

22.3

SPAT1284

SPAT

Extensive health certificate

2.6

22.2

170

584

N05CD02

ATC

nitrazepam; oral

3.5

22.2

106

266

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.3

22.2

222

876

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

8.3

22.1

Z51.88

ICD-10 Finland

Other specified medical care

2.6

22.0

163

551

N06AX22

ATC

agomelatine; oral

7.3

22.0

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.9

21.8

137

419

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

21.8

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

21.8

F0011, G301

ICD-10 Finland

+∞

21.8

30180

ICD-8 Finland

Personality disorders, Immatura

+∞

21.8

R60.0

ICD-10 Finland

Localized oedema

1.5

21.7

796

4804

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

21.7

170

591

F02.89

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without information of additional symptoms

47.5

21.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

21.6

1339

8951

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.5

21.6

174

617

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

8.0

21.6

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

24.8

21.6

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

24.8

21.6

J01MA02

ATC

ciprofloxacin; systemic

1.3

21.5

2603

19237

F20

ICD-10 Finland

Schizophrenia

202.1

21.4

I95.9

ICD-10 Finland

Hypotension, unspecified

3.2

21.4

117

326

S22.3

ICD-10 Finland

Fracture of rib

1.8

21.4

406

2061

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

3.1

21.3

123

356

XF606

NOMESCO Finland

Ortostatic test

4.1

21.3

183

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

21.2

1799

L75

ICPC

Fracture: femur

3.4

21.2

105

272

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

21.1

595

7528

G04BD07

ATC

tolterodine; oral

1.8

21.0

364

1791

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

20.9

240

1009

L57.0

ICD-10 Finland

Actinic keratosis

0.6

20.9

440

5908

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

20.9

260

1132

R51.80

ICD-10 Finland

Headache

1.5

20.8

668

3911

S97

ICPC

Chronic ulcer skin

1.7

20.7

409

2100

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

20.7

151

506

R5110

SPAT

2.3

20.7

207

818

F41.3

ICD-10 Finland

Other mixed anxiety disorders

30.8

20.6

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

20.6

273

1219

A04AA02

ATC

granisetron; systemic, transdermal

0.5

20.5

137

2498

R50.9

ICD-10 Finland

Fever, unspecified

1.5

20.5

816

5015

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

3.4

20.4

102

266

V03AA01

ATC

4.8

20.3

130

F45.0

ICD-10 Finland

Somatization disorder

33.9

20.3

P74

ICPC

Anxiety disorder/anxiety state

3.8

20.3

204

N06AX18

ATC

reboxetine; oral

6.2

20.3

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.5

20.2

164

583

A10BB12

ATC

glimepiride; oral

1.6

20.2

536

2994

M01AH05

ATC

etoricoxib; oral

0.8

20.2

2668

26990

AA1AA

NOMESCO Finland

Head X-ray examination

3.8

20.1

206

P27

ICPC

Fear of mental disorder

9.5

20.1

Z60.8

ICD-10 Finland

Other problems related to social environment

17.6

20.1

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

20.0

258

1139

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.6

19.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

19.9

622

3618

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

+∞

19.8

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

+∞

19.8

F60.7

ICD-10 Finland

Dependent personality disorder

+∞

19.8

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

19.6

630

7795

P05

ICPC

Senility, feeling/behaving old

7.3

19.6

F41.00

ICD-10 Finland

Moderate panic disorder

24.6

19.5

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

184.5

19.5

F30.9

ICD-10 Finland

Manic episode, unspecified

96.7

19.4

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.4

19.4

168

618

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.9

19.4

292

1370

U13

ICPC

Bladder symptom/complaint other

2.1

19.3

217

906

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

19.3

1838

13104

L01BC06

ATC

capecitabine; oral

0.4

19.1

1484

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

22.4

19.0

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.0

19.0

111

325

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

42.2

18.9

L04AA31

ATC

teriflunomide; oral

28.6

18.8

S20.2

ICD-10 Finland

Contusion of thorax

1.9

18.8

278

1294

S09.9

ICD-10 Finland

Unspecified injury of head

3.6

18.8

218

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

+∞

18.8

F20.10

ICD-10 Finland

Raise schizophrenia continuously

+∞

18.8

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

+∞

18.8

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

18.8

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

+∞

18.8

F0232, G20

ICD-10 Finland

+∞

18.8

F21

ICD-10 Finland

Schizotypal disorder

+∞

18.8

N05AB01

ATC

dixyrazine; systemic

5.7

18.8

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.8

18.7

193

B01AC04

ATC

clopidogrel; oral

1.4

18.6

1282

8699

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

18.6

1764

12556

N04BC09

ATC

rotigotine; transdermal

5.5

18.6

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

64.5

18.6

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

64.5

18.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

18.5

704

4278

F61

ICD-10 Finland

Mixed and other personality disorders

175.7

18.5

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

92.3

18.5

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.6

18.4

138

472

R13

ICD-10 Finland

Dysphagia

1.7

18.4

417

2228

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

18.3

391

2054

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.9

18.3

175

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

35.1

18.3

F33.8

ICD-10 Finland

Other recurrent depressive disorders

35.1

18.3

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

5.9

18.2

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.8

18.2

184

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

18.2

1680

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

18.2

286

1363

N03AX11

ATC

topiramate; oral

3.7

18.1

190

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

18.1

252

1151

SPAT1281

SPAT

Other administrative function

1.6

18.0

519

2959

R40.2

ICD-10 Finland

Coma, unspecified

4.6

18.0

124

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.7

17.9

191

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

17.9

614

3647

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

5.1

17.9

N05AE04

ATC

ziprasidone; systemic

+∞

17.8

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

+∞

17.8

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

+∞

17.8

F20.8

ICD-10 Finland

Other schizophrenia

+∞

17.8

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

+∞

17.8

-2

ICPC

6.3

17.8

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

17.8

1366

14817

RT150

NOMESCO Finland

48.3

17.8

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.5

17.8

567

3310

Z75.0

ICD-10 Finland

Medical services not available in home

19.8

17.7

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

61.6

17.6

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.7

17.6

190

Y07

ICD-10 Finland

Other maltreatment

11.6

17.6

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

11.6

17.6

F43.1

ICD-10 Finland

Post-traumatic stress disorder

11.6

17.6

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

5.9

17.6

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

166.9

17.6

H04AA01

ATC

glucagon; nasal, parenteral

3.4

17.5

222

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

87.9

17.5

F22.8

ICD-10 Finland

Other persistent delusional disorders

87.9

17.5

E000001

ATC

1.4

17.5

1095

7310

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

17.5

406

2186

G04BD09

ATC

trospium; oral

2.1

17.4

203

860

A05

ICPC

Feeling ill

2.0

17.4

240

1091

RS222

NOMESCO Finland

3.6

17.4

201

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.4

17.3

2AB04

NOMESCO Finland

13.9

17.3

D11

ICPC

Diarrhoea

1.6

17.2

478

2699

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

17.2

238

1082

S00.8

ICD-10 Finland

Superficial injury of other parts of head

3.1

17.1

270

SPAT1241

SPAT

Extensive assessment of psychosocial situation

8.4

17.0

L76

ICPC

Fracture: other

2.1

17.0

187

775

N05CF02

ATC

zolpidem; oral

1.4

17.0

821

5229

R45.1

ICD-10 Finland

Restlessness and agitation

22.0

16.9

N03AX12

ATC

gabapentin; oral

1.4

16.9

896

5808

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

9.1

16.9

S01.8

ICD-10 Finland

Open wound of other parts of head

3.3

16.8

239

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

16.8

F0024, G308

ICD-10 Finland

+∞

16.8

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

+∞

16.8

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

+∞

16.8

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

16.8

736

4600

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

16.8

632

3831

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

28.9

16.8

C07AA05

ATC

propranolol; systemic

1.4

16.8

874

5647

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

16.7

167

662

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

158.1

16.6

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

83.5

16.6

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

9.6

16.5

E0000UV

ATC

1.3

16.5

2290

17062

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

6.4

16.5

A23

ICPC

Risk factor NOS

1.8

16.4

279

1367

S28

ICPC

Limited function/disability (S)

5.0

16.2

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

4.0

16.2

142

A10BA02

ATC

metformin; oral

1.3

16.2

1978

14505

G04CA02

ATC

tamsulosin; oral

1.3

16.2

1803

13068

B01AA03

ATC

warfarin; systemic

1.3

16.2

1523

10797

A02BC03

ATC

lansoprazole; oral

1.3

16.1

1808

13115

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

16.0

1892

13811

R2110

NOMESCO Finland

Giving the first information

1.7

15.9

364

1954

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

+∞

15.8

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

15.8

29999

ICD-8 Finland

Unspecified psychosis

+∞

15.8

30680

ICD-8 Finland

Special symptoms not elsewhere classified, Cephalalgia

+∞

15.8

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.3

15.8

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

55.6

15.8

WX402

NOMESCO Finland

General anaesthesia

0.7

15.7

535

6563

XA400

NOMESCO Finland

EEG

5.0

15.7

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

15.6

154

606

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

149.3

15.6

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.2

15.6

234

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.7

15.5

111

369

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

15.5

407

2267

SPAT1104

SPAT

Monitoring of emergency patient

1.6

15.5

441

2509

A10AA02

ATC

2.2

15.4

153

605

Z43.5

ICD-10 Finland

Attention to cystostomy

4.8

15.4

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

15.4

186

802

EBA00

NOMESCO Finland

Extraction of tooth

1.3

15.4

1806

13163

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

35.1

15.3

D17

ICPC

Incontinence of bowel

3.4

15.2

191

S06.2

ICD-10 Finland

Diffuse brain injury

3.9

15.1

139

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

15.1

249

1210

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

15.1

304

1572

F32.0

ICD-10 Finland

Mild depressive episode

3.4

15.0

193

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

15.0

307

1594

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

12.5

15.0

OAB43

SPAT

0.4

14.9

1162

S01

ICD-10 Finland

Open wound of head

3.1

14.9

237

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

+∞

14.8

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

+∞

14.8

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

+∞

14.8

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

+∞

14.8

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

+∞

14.8

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

+∞

14.8

29800

ICD-8 Finland

Other psychoses, Reactive depressive psychosis

+∞

14.8

31099

ICD-8 Finland

Borderline mental retardation, Other and unspecified

+∞

14.8

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

+∞

14.8

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

14.8

125

458

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

14.6

14.8

P18

ICPC

Medication abuse

16.2

14.8

F01.8

ICD-10 Finland

Other vascular dementia

74.7

14.7

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

74.7

14.7

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.4

14.7

183

R45.5

ICD-10 Finland

Hostility

140.5

14.7

R4130

NOMESCO Finland

Speech therapy

2.2

14.6

148

594

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.8

14.6

295

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

14.5

646

4048

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

23.1

14.5

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.7

14.5

323

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

14.5

1024

6954

C07AB07

ATC

bisoprolol; oral

1.2

14.4

3511

27686

L04AX07

ATC

dimethyl fumarate; oral

19.3

14.4

SPAT1153

SPAT

Removal of sutures

0.8

14.4

1842

18918

SPAT1285

SPAT

Provision of consultation response

1.6

14.3

365

2018

A02BA02

ATC

ranitidine; systemic

1.3

14.3

1206

8399

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

14.3

480

2835

I50.0

ICD-10 Finland

Congestive heart failure

1.5

14.3

449

2612

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

14.3

135

523

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

14.3

446

2593

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

25.1

14.2

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.5

14.2

113

401

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

39.5

14.1

Z11

ICPC

Compliance/being ill problem

5.2

14.1

A01AB09

ATC

miconazole; local oral

1.5

14.0

508

3052

SPAT1014

SPAT

Treatment of eyes

2.3

14.0

125

473

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

14.0

543

3312

A02BC01

ATC

omeprazole; systemic

1.3

13.9

1716

12554

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.5

13.9

168

2971A

ICD-9 Finland

Paranoid states, Paranoia

+∞

13.9

F009, F03

ICD-10 Finland

+∞

13.9

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

+∞

13.9

F25

ICD-10 Finland

Schizoaffective disorders

+∞

13.9

F0029, G308

ICD-10 Finland

+∞

13.9

F50.9

ICD-10 Finland

Eating disorder, unspecified

+∞

13.9

X78

ICD-10 Finland

Intentional self-harm by sharp object

+∞

13.9

P73

ICPC

Affective psychosis

+∞

13.9

S80.0

ICD-10 Finland

Contusion of knee

1.7

13.8

296

1559

J01DB01

ATC

cefalexin; oral

1.2

13.8

5253

43267

F01.84

ICD-10 Finland

Other specified vascular dementia other mixed symptoms of mixed type

70.3

13.7

LAITO

NOMESCO Finland

70.3

13.7

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.5

13.7

105

366

Z08

ICPC

Social welfare problem

4.1

13.7

113

N05AE03

ATC

sertindole; oral

131.7

13.7

4AA23

NOMESCO Finland

131.7

13.7

N80

ICPC

Head injury other

2.5

13.7

104

361

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

13.6

213

1018

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

5.9

13.5

T05

ICPC

Feeding problem of adult

4.8

13.4

B01AC07

ATC

dipyridamole; systemic

1.7

13.4

273

1418

G40.89

ICD-10 Finland

Other epilepsy

5.8

13.4

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.3

13.3

128

500

R4120

NOMESCO Finland

Occupational therapy

1.6

13.3

348

1938

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

13.3

170

752

Y94.1

ICD-10 Finland

Accident in connection with service housing

37.3

13.2

N04BC02

ATC

pergolide; oral

16.8

13.2

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.2

13.2

185

U28

ICPC

Limited function/disability (U)

2.8

13.1

268

A10BH01

ATC

sitagliptin; oral

1.4

13.1

665

4270

T68

ICD-10 Finland

Hypothermia

6.7

13.1

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

13.1

235

1176

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.6

13.0

145

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

46.8

13.0

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.2

13.0

N07XX09

ATC

[U] dimethyl fumarate; oral

26.3

13.0

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

5.4

13.0

RS121

NOMESCO Finland

5.2

12.9

29630

ICD-8 Finland

Affective psychoses, Manic-depressive psychosis, circular type

+∞

12.9

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

+∞

12.9

2967A

ICD-9 Finland

Affective psychoses, Bipolar affective disorder, unspecified

+∞

12.9

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

12.9

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

+∞

12.9

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

12.9

E9599

ICD-8 Finland

Late effect of self-inflicted injury

+∞

12.9

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

12.9

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

12.9

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

12.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

12.8

1852

13776

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.4

12.8

1199

A03FA02

ATC

cisapride; oral, rectal

1.5

12.8

456

2729

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

12.8

289

1546

D07AA02

ATC

hydrocortisone; topical

1.4

12.8

618

3934

F10.8

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders

122.9

12.7

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

122.9

12.7

F60.0

ICD-10 Finland

Paranoid personality disorder

122.9

12.7

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.1

12.7

149

639

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

12.7

134

549

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

12.7

104

377

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

29.9

12.6

C01DA14

ATC

isosorbide mononitrate; oral

1.3

12.6

1121

7855

J01DA01

ATC

[U] cefalexin; systemic

1.2

12.5

3625

28895

F06.32

ICD-10 Finland

Organic depression

12.9

12.5

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

12.4

168

761

C07AB02

ATC

metoprolol; systemic

1.3

12.4

1453

10544

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

6.8

12.4

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

35.1

12.3

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

35.1

12.3

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

35.1

12.3

R07.3

ICD-10 Finland

Other chest pain

1.4

12.3

540

3375

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

3.2

12.3

176

C09AA05

ATC

ramipril; oral

1.2

12.3

1845

13775

SPAT1244

SPAT

Occupational therapy

3.0

12.3

215

E16.19

ICD-10 Finland

Other specified hypoglycaemia

6.6

12.2

N06AA10

ATC

nortriptyline; systemic

2.6

12.2

291

A86

ICD-10 Finland

Unspecified viral encephalitis

4.8

12.1

RS230

NOMESCO Finland

6.0

12.1

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

24.9

12.1

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

24.9

12.1

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

12.0

301

1655

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

12.0

767

5121

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

+∞

11.9

F10.74

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence

+∞

11.9

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

+∞

11.9

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

+∞

11.9

F30.1

ICD-10 Finland

Mania without psychotic symptoms

+∞

11.9

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

+∞

11.9

2961A

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]

+∞

11.9

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

+∞

11.9

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

+∞

11.9

F0004, G300

ICD-10 Finland

+∞

11.9

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

+∞

11.9

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

+∞

11.9

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

+∞

11.9

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.8

11.9

776

8651

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

61.5

11.9

F01.33

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression

61.5

11.9

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

11.8

601

3858

A10AA01

ATC

2.3

11.8

107

407

NF3AA

NOMESCO Finland

Femur X-ray examination

2.2

11.8

116

462

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

6.6

11.8

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

114.1

11.8

F34.0

ICD-10 Finland

Cyclothymia

114.1

11.8

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.3

11.8

112

437

A10BH05

ATC

linagliptin; oral

1.5

11.8

357

2064

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

28.1

11.7

R40.0

ICD-10 Finland

Somnolence

6.9

11.7

S06.9

ICD-10 Finland

Intracranial injury, unspecified

4.5

11.7

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

5.2

11.7

G04BD11

ATC

fesoterodine; oral

1.7

11.7

221

1125

R4150

NOMESCO Finland

Neuropsychological rehabilitation

5.5

11.7

WYA30

SPAT

4.8

11.6

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

11.6

153

2289

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

11.5

688

4540

SPAT1165

SPAT

Peritoneal dialysis

10.7

11.5

N02AJ06

ATC

codeine and paracetamol; systemic

0.8

11.5

1621

16572

N04BC06

ATC

cabergoline; oral (dopamine agonists)

5.6

11.4

Z50.1

ICD-10 Finland

Other physical therapy

1.6

11.4

330

1884

SPAT1236

SPAT

Informing family of child’s disability

2.0

11.4

151

679

X58

ICD-10 Finland

Exposure to other specified factors

1.4

11.3

628

4092

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.0

11.3

192

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

10.2

11.2

79301

ICD-8 Finland

Observation, without need for further medical care, Observatio post tentationem suicidii

23.4

11.2

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

11.2

452

2779

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

11.2

422

2557

S82

ICPC

Naevus/mole

0.7

11.2

426

5141

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.3

11.2

108

424

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

13.9

11.2

RS210

NOMESCO Finland

13.9

11.2

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

11.2

217

2969

XKD00

NOMESCO Finland

Uroflowmetry

1.3

11.2

1291

9339

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

11.2

160

743

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

15.8

11.1

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

6.4

11.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

11.1

997

6987

S42.0

ICD-10 Finland

Fracture of clavicle

2.1

11.1

127

538

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

11.1

316

1798

RS221

NOMESCO Finland

2.8

11.1

234

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

11.1

1441

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.5

11.0

1307

R1260

NOMESCO Finland

Evaluation of communicative skills

2.2

11.0

117

480

SPAT1255

SPAT

Intravenous administration of medicine

1.5

11.0

409

2475

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

6.5

10.9

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

10.9

F0024, G301

ICD-10 Finland

+∞

10.9

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

10.9

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

+∞

10.9

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

+∞

10.9

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

+∞

10.9

F28

ICD-10 Finland

Other nonorganic psychotic disorders

+∞

10.9

F0203, G310

ICD-10 Finland

+∞

10.9

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

+∞

10.9

29500

ICD-8 Finland

Schizophrenia, Simple type

+∞

10.9

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

+∞

10.9

F0023, G308

ICD-10 Finland

+∞

10.9

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

10.9

F0200, G310

ICD-10 Finland

+∞

10.9

F10.7

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Residual and late-onset psychotic disorder

+∞

10.9

F02.00

ICD-10 Finland

Dementia in Pick's disease without additional symptoms

+∞

10.9

SPAT1265

SPAT

Breathalyser

5.4

10.8

F01.89

ICD-10 Finland

Other specified vascular dementia without information on additional symptoms

105.3

10.8

IEY01

NOMESCO Finland

Psychoeducation, individual

105.3

10.8

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

10.8

149

683

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

10.8

1514

11196

N30

ICD-10 Finland

Cystitis

1.5

10.7

361

2136

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

10.7

190

947

R44.0

ICD-10 Finland

Auditory hallucinations

9.2

10.7

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

8.4

10.6

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.0

10.6

139

625

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

30.7

10.5

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

30.7

10.5

AA1XD

NOMESCO Finland

Other special CT of head and brain

4.3

10.5

G25.1

ICD-10 Finland

Drug-induced tremor

9.7

10.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

10.5

3140

24946

GD1AA

SPAT

0.5

10.5

1184

N07

ICPC

Convulsion/seizure

8.8

10.4

XF606

SPAT

5.5

10.3

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.0

10.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

10.3

185

929

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.1

10.3

119

509

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

10.3

1294

9447

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

9.2

10.3

IHZ08

SPAT

38.0

10.2

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

38.0

10.2

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

10.2

547

3541

N05AC01

ATC

periciazine; systemic

8.4

10.2

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

10.2

303

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

3.8

10.2

A02BC02

ATC

pantoprazole; systemic

1.2

10.1

4226

34486

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.0

10.1

120

518

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.9

10.1

157

750

N06AC02

ATC

5.1

10.1

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.0

10.1

127

563

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

10.1

361

2167

HA1RA

SPAT

0.3

10.1

547

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.4

10.1

325

AA1CG

SPAT

3.8

10.0

F06.30

ICD-10 Finland

Organic manic syndrome

52.6

10.0

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

52.6

10.0

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.7

10.0

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

13.6

10.0

ZXA00

NOMESCO Finland

Right side

1.2

9.9

1807

13705

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

+∞

9.9

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

+∞

9.9

F0022, G308

ICD-10 Finland

+∞

9.9

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

+∞

9.9

30020

ICD-8 Finland

Neuroses, Phobic neurosis

+∞

9.9

29620

ICD-8 Finland

Affective psychoses, Manic depressive psychosis, depressed type

+∞

9.9

30050

ICD-8 Finland

Neuroses, Neurasthenia

+∞

9.9

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

9.9

29540

ICD-8 Finland

Acute schizophrenia episode

+∞

9.9

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

+∞

9.9

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

+∞

9.9

3016A

ICD-9 Finland

Personality disorders, Dependent personality disorder

+∞

9.9

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

+∞

9.9

G04BD10

ATC

darifenacin; oral

3.0

9.9

169

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.6

9.9

245

1347

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

9.9

816

T08

ICPC

Weight loss

2.2

9.9

369

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

96.5

9.9

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

96.5

9.9

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

96.5

9.9

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

96.5

9.9

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.3

9.8

342

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

3.0

9.8

156

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.7

9.8

184

938

I95.2

ICD-10 Finland

Hypotension due to drugs

3.2

9.8

142

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

9.8

182

924

T89

ICPC

Diabetes insulin dependent

1.8

9.8

154

739

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

9.7

556

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.9

9.7

172

N43

ICPC

Neurological, Other diagnostic procedure

3.7

9.7

U29

ICPC

Urinary symptom/complaint other

1.8

9.7

172

861

S22

ICPC

Nail symptom/complaint

1.5

9.7

357

2158

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

9.6

218

2886

R63.1

ICD-10 Finland

Polydipsia

9.8

9.6

Z01

ICPC

Poverty/financial problem

9.8

9.6

G41.0

ICD-10 Finland

Grand mal status epilepticus

9.8

9.6

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.5

9.6

1369

M54.5

ICD-10 Finland

Low back pain

1.2

9.6

1697

12827

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

9.6

444

2804

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

9.6

1914

19018

ZXC96

NOMESCO Finland

Robot assisted procedure

0.4

9.6

1011

Z74.0

ICD-10 Finland

Need for assistance due to reduced mobility

14.0

9.6

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

14.0

9.6

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

9.5

140

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

20.5

9.5

U07

ICPC

Urine symptom/complaint other

1.5

9.5

371

2267

AAF00

NOMESCO Finland

Ventriculostomy

3.5

9.5

112

P04

ICPC

Feeling/behaving irritable/angry

8.0

9.5

R52.9

ICD-10 Finland

Pain, unspecified

1.4

9.5

429

2695

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

9.5

143

2068

V03AB30

ATC

4.5

9.5

AA1AD

SPAT

5.9

9.5

A08

ICPC

Swelling

1.6

9.5

272

1553

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.2

9.5

136

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.0

9.5

159

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

9.4

1436

14624

S20

ICPC

Corn/callosity

1.9

9.4

136

636

Z93.5

ICD-10 Finland

Cystostomy status

6.1

9.4

7803A

ICD-9 Finland

General symptoms, Convulsions

4.1

9.4

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.4

9.4

118

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

9.3

105

444

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

35.1

9.3

E51.2

ICD-10 Finland

Wernicke encephalopathy

35.1

9.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

9.3

241

1342

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.7

9.3

176

898

SPAT1111

SPAT

Planning of analgesia

2.5

9.3

235

S32.5

ICD-10 Finland

Fracture of pubis

3.1

9.3

138

WX111

NOMESCO Finland

Local infiltration anesthesia

0.5

9.3

1365

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

9.2

262

A02BX02

ATC

sucralfate; oral

1.6

9.2

224

1227

N19

ICD-10 Finland

Unspecified kidney failure

1.6

9.2

211

1139

T90

ICPC

Diabetes non-insulin dependent

1.2

9.2

1630

12315

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.6

9.2

235

1304

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

6.2

9.2

D10

ICPC

Vomiting

1.9

9.2

138

656

K92.1

ICD-10 Finland

Melaena

1.5

9.2

316

1882

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.7

9.1

174

889

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

9.1

495

3217

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

9.1

2546

20031

N03AX15

ATC

zonisamide; oral

14.6

9.1

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

8.8

9.1

K28

ICPC

Limited function/disability (K)

1.8

9.1

147

716

F33

ICD-10 Finland

Recurrent depressive disorder

5.3

9.1

F30.0

ICD-10 Finland

Hypomania

48.2

9.1

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

48.2

9.1

F06.33

ICD-10 Finland

Organic mood syndrome

48.2

9.1

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.9

9.1

S72.2

ICD-10 Finland

Subtrochanteric fracture

3.2

9.1

131

OAB48

SPAT

0.3

9.1

609

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

7.4

9.1

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

9.0

673

4592

WF002

NOMESCO Finland

Radical radiotherapy

0.6

9.0

187

2522

R03BB04

ATC

tiotropium bromide; inhalant

1.3

9.0

561

3724

N06AX17

ATC

milnacipran; oral

4.0

9.0

DJA10

NOMESCO Finland

Biopsy of septum of nose

10.7

9.0

G40.10

ICD-10 Finland

Simple partial seizures

3.2

9.0

122

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

9.0

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

9.0

1387

N02AC04

ATC

dextropropoxyphene; oral

1.6

9.0

205

1105

K07

ICPC

Swollen ankles/oedema

1.5

9.0

295

1742

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

9.0

111

1686

Z50.5

ICD-10 Finland

Speech therapy

2.6

8.9

224

F0204, G310

ICD-10 Finland

+∞

8.9

29560

ICD-8 Finland

Residual schizophrenia

+∞

8.9

30430

ICD-8 Finland

Drug dependence, Other hypnotics and sedatives or tranquillisers

+∞

8.9

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

+∞

8.9

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

+∞

8.9

30010

ICD-8 Finland

Neuroses, Hysterical neurosis

+∞

8.9

IEV99

NOMESCO Finland

Other psychiatric network intervention

+∞

8.9

F10.79

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol UNS

+∞

8.9

N05AX13

ATC

paliperidone; systemic

+∞

8.9

30399

ICD-8 Finland

Other and unspecified alcoholism

+∞

8.9

2961B

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]

+∞

8.9

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

+∞

8.9

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

+∞

8.9

F0230, G20

ICD-10 Finland

+∞

8.9

F0234, G20

ICD-10 Finland

+∞

8.9

F33.31

ICD-10 Finland

Recurrent depression, severe episode of somatic syndrome

+∞

8.9

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

+∞

8.9

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

+∞

8.9

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

+∞

8.9

F000, G300

ICD-10 Finland

+∞

8.9

F01.13

ICD-10 Finland

The other additional symptoms of multi-infarct dementia, mainly depression

+∞

8.9

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

+∞

8.9

F01.81

ICD-10 Finland

Other specified vascular dementia has other additional symptoms, mainly paranoidism

+∞

8.9

F0012, G301

ICD-10 Finland

+∞

8.9

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.7

8.9

188

F002, G308

ICD-10 Finland

87.8

8.9

Q90.9

ICD-10 Finland

Down syndrome, unspecified

87.8

8.9

F91.9

ICD-10 Finland

Conduct disorder, unspecified

87.8

8.9

G02CB01

ATC

bromocriptine; systemic

3.1

8.9

133

G91.1

ICD-10 Finland

Obstructive hydrocephalus

4.9

8.9

S01.3

ICD-10 Finland

Open wound of ear

2.6

8.9

219

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.2

8.9

366

-1

ICPC

2.0

8.9

115

518

R51

ICD-10 Finland

Headache

1.7

8.9

192

1020

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

26.3

8.8

A04AA55

ATC

palonosetron, combinations; systemic

0.4

8.8

668

A02BA04

ATC

nizatidine; systemic

1.4

8.8

424

2700

R47.1

ICD-10 Finland

Dysarthria and anarthria

2.7

8.8

193

34599

ICD-8 Finland

Epilepsy, Other and unspecified

4.8

8.7

AAF15

NOMESCO Finland

Ventriculoatrial shunt

5.5

8.7

H3601, E113

ICD-10 Finland

2.0

8.7

105

458

A78

ICPC

Infectious disease other/NOS

2.5

8.7

231

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

19.0

8.7

A99

ICPC

Disease/condition unspecnature/site

1.4

8.7

471

3059

XCK00

NOMESCO Finland

Perimetry

1.4

8.7

439

2818

SPAT1227

SPAT

Substance abuse rehabilitation

8.8

8.7

C10AA05

ATC

atorvastatin; oral

1.2

8.7

2981

23825

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

8.6

1734

13246

SPAT1277

SPAT

Instruction concerning legal protection and patient’s rights

7.9

8.6

J01MA12

ATC

levofloxacin; systemic

1.2

8.6

1130

8275

WX892

NOMESCO Finland

Monitored bed care

1.4

8.6

463

3004

D09

ICPC

Nausea

1.8

8.6

153

768

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.1

8.6

132

R82.7

ICD-10 Finland

Abnormal findings on microbiological examination of urine

5.4

8.6

NG1AA

SPAT

0.3

8.6

590

WX730

NOMESCO Finland

Conventional respirator

2.2

8.5

355

QAB00

NOMESCO Finland

Suture of skin of head or neck

2.4

8.5

264

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.8

8.5

141

693

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.4

8.5

100

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

32.2

8.5

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

8.5

390

2465

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

8.4

940

U05

ICPC

Urination problems other

1.5

8.4

304

1829

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

8.3

8.4

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

8.4

217

1211

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

2.8

8.4

159

T74.1

ICD-10 Finland

Physical abuse

3.9

8.4

M48.0

ICD-10 Finland

Spinal stenosis

1.3

8.3

848

6030

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.2

8.3

306

R01AD12

ATC

fluticasone furoate; nasal

0.8

8.3

892

9407

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.6

8.3

185

995

L03AA13

ATC

pegfilgrastim; parenteral

0.5

8.3

1328

A10BB07

ATC

glipizide; oral

2.2

8.2

298

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.8

8.2

128

617

A41.8

ICD-10 Finland

Other specified sepsis

2.0

8.2

106

478

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.3

8.2

264

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

8.2

2074

16153

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.6

8.2

C01AA05

ATC

digoxin; systemic

1.4

8.2

466

3056

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.8

8.2

516

5790

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

8.1

357

2236

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.7

8.1

242

3041

359

Kela drug reimbursment

Mirabegroni

2.7

8.1

167

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.0

8.1

135

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.2

8.1

335

D01AC02

ATC

miconazole; topical

1.4

8.1

434

2815

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.3

8.1

270

I67.4

ICD-10 Finland

Hypertensive encephalopathy

12.3

8.0

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.6

8.0

184

N06AA22

ATC

3.9

8.0

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.9

8.0

112

520

Angiography of the heart and coronary arteries

1.4

8.0

459

3011

205

Kela drug reimbursment

Chronic hypertension

1.2

8.0

2085

16273

R54

ICD-10 Finland

Senility

7.0

8.0

F02.04

ICD-10 Finland

Dementia in Pick's disease other additional symptoms of mixed type

79.0

7.9

ICB03

SPAT

79.0

7.9

Z91.5

ICD-10 Finland

Personal history of self-harm

79.0

7.9

F02.82

ICD-10 Finland

Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations

79.0

7.9

F07.0

ICD-10 Finland

Organic personality disorder

79.0

7.9

F01.14

ICD-10 Finland

Multi-infarct dementia's other mixed symptoms of mixed type

79.0

7.9

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

79.0

7.9

OAA80

SPAT

0.2

7.9

290

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

24.1

7.9

F02.29*G10

ICD-10 Finland

Dementia in Huntington's disease without information on additional symptoms

+∞

7.9

F02.3

ICD-10 Finland

Dementia in Parkinson disease

+∞

7.9

F0021, G301

ICD-10 Finland

+∞

7.9

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

+∞

7.9

F48.9

ICD-10 Finland

Neurotic disorder, unspecified

+∞

7.9

3000B

ICD-9 Finland

Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]

+∞

7.9

F23.00

ICD-10 Finland

Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor

+∞

7.9

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

+∞

7.9

F0021, G308

ICD-10 Finland

+∞

7.9

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

+∞

7.9

F20.32

ICD-10 Finland

Undifferentiated schizophrenia stable periodically

+∞

7.9

F02.89*M30.0

ICD-10 Finland

Dementia in polyarteritis nodosa

+∞

7.9

29100

ICD-8 Finland

Alcoholic psychosis, Delirium tremens

+∞

7.9

29610

ICD-8 Finland

Affective psychoses, Manic-depression psychosis, manic type

+∞

7.9

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

+∞

7.9

N05AA03

ATC

promazine; systemic

+∞

7.9

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

+∞

7.9

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

+∞

7.9

F10.59

ICD-10 Finland

Alcohol psychosis, mixed type

+∞

7.9

29700

ICD-8 Finland

Paranoid states, Paranoia

+∞

7.9

30799

ICD-8 Finland

Transient situational disturbances

+∞

7.9

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

+∞

7.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.9

4495

37190

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

7.9

248

1450

F06.4

ICD-10 Finland

Organic anxiety disorder

17.5

7.9

G72.9

ICD-10 Finland

Myopathy, unspecified

2.8

7.8

151

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

10.1

7.8

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.5

7.8

1123

L03AA02

ATC

filgrastim; parenteral

0.5

7.8

945

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

7.8

1654

12679

N01

ICPC

Headache

1.4

7.8

348

2186

Z27

ICPC

Fear of a social problem

5.5

7.8

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

5.5

7.8

N05CD08

ATC

midazolam; nasal, systemic

1.9

7.8

118

562

N06BA07

ATC

modafinil; oral

8.8

7.8

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

7.8

357

2256

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

2.8

7.8

147

N06BA04

ATC

methylphenidate; oral

7.2

7.7

TNC33

NOMESCO Finland

Custom moulded brace, elbow or forearm

5.2

7.7

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

5.8

7.7

R25.2

ICD-10 Finland

Cramp and spasm

1.9

7.7

112

528

SPF30

NOMESCO Finland

Soling for prothesis

1.8

7.7

133

665

SPAT1042

SPAT

Guidance concerning balance maintenance

2.9

7.7

137

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

0.3

7.7

448

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.3

7.7

448

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.5

7.7

206

RF220

NOMESCO Finland

2.0

7.7

386

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.2

7.7

296

R4110

NOMESCO Finland

Physiotherapy

1.2

7.6

1602

12267

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

7.6

681

4765

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

4.0

7.6

E970A

ICD-9 Finland

Injury due to legal intervention by firearms

29.2

7.6

N05BA05

ATC

potassium clorazepate; oral

3.0

7.6

127

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

7.6

279

1691

C10AA02

ATC

lovastatin; oral

1.4

7.5

293

1793

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

8.3

7.5

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.8

7.5

140

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.5

1265

9493

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

15.0

7.5

NF1AA

SPAT

0.2

7.5

347

W0A10

NOMESCO Finland

Mapping of psychosocial situation

19.3

7.5

IAB11

NOMESCO Finland

Psychiatric mood consultation

19.3

7.5

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

5.9

7.5

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

5.9

7.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.2

7.5

1012

7432

XX3DW

NOMESCO Finland

Time consuming IT work

0.8

7.4

418

4764

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.8

7.4

121

594

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

4.3

7.4

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.9

7.4

101

465

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.3

7.4

801

5739

A12BA01

ATC

potassium chloride; oral

1.5

7.4

255

1523

N05AB02

ATC

fluphenazine; systemic

3.6

7.4

JN4AD

NOMESCO Finland

Body CT examination

0.7

7.4

312

3702

A13

ICPC

Concern/fear medical treatment

1.9

7.3

443

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

3.6

7.3

3459X

ICD-9 Finland

Epilepsy, unspecified

7.1

7.3

A03CA02

ATC

clidinium and psycholeptics; oral

1.4

7.3

337

2134

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

2.6

7.3

167

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

39.5

7.3

A81.0

ICD-10 Finland

Creutzfeldt-Jakob disease

39.5

7.3

IBA03

NOMESCO Finland

Psychotherapy evaluation

39.5

7.3

R31

ICD-10 Finland

Unspecified haematuria

1.3

7.2

674

4743

SPAT1235

SPAT

Mental health, emotional support

6.0

7.2

WZC30

NOMESCO Finland

Teaching

0.8

7.2

555

6077

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

2.2

7.2

288

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.2

7.2

1037

7661

S30.1

ICD-10 Finland

Contusion of abdominal wall

2.3

7.2

242

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.5

7.2

804

A07AA02

ATC

nystatin; oral

1.4

7.2

347

2213

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

3.2

7.2

100

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.8

7.1

109

523

P58

ICPC

Psychological, Therapeutic counselling/listening

3.4

7.1

PA7BD

NOMESCO Finland

CT angiography of neck and brain

1.8

7.1

111

538

N06AE02

ATC

7.4

7.1

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.0

7.1

P20

ICD-10 Finland

Intrauterine hypoxia

16.1

7.1

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.7

7.0

151

805

A34

ICPC

General and Unspecified, Blood test

2.1

7.0

296

R52.2

ICD-10 Finland

Other chronic pain

1.7

7.0

137

709

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.6

7.0

180

1006

F22

ICD-10 Finland

Persistent delusional disorders

70.2

7.0

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

70.2

7.0

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

70.2

7.0

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

70.2

7.0

IER01

NOMESCO Finland

Psychoeducation, group

70.2

7.0

F60.2

ICD-10 Finland

Dissocial personality disorder

70.2

7.0

A03FA01

ATC

metoclopramide; systemic, rectal

0.8

7.0

831

8690

U08

ICPC

Urinary retention

1.8

7.0

117

577

H53.4

ICD-10 Finland

Visual field defects

1.8

7.0

121

607

N05BB01

ATC

hydroxyzine; systemic

1.5

7.0

250

1509

G21.8

ICD-10 Finland

Other secondary parkinsonism

5.3

7.0

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

6.9

171

944

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

6.9

1591

12264

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.9

6.9

121

2962C

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]

+∞

6.9

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

+∞

6.9

2913A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal hallucinosis

+∞

6.9

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

+∞

6.9

F0282, G318

ICD-10 Finland

+∞

6.9

29550

ICD-8 Finland

Latent schizophrenia

+∞

6.9

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

+∞

6.9

F02.89*T58

ICD-10 Finland

Dementia with carbon monoxide intoxication

+∞

6.9

F01.32

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations

+∞

6.9

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

6.9

F0013, G301

ICD-10 Finland

+∞

6.9

F10.6

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Amnesic syndrome

+∞

6.9

F60.1

ICD-10 Finland

Schizoid personality disorder

+∞

6.9

IEP01

NOMESCO Finland

Psychoeducation, family

+∞

6.9

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

+∞

6.9

IEP99

NOMESCO Finland

Other psychiatric family intervention

+∞

6.9

IAB12

NOMESCO Finland

Psychiatric psychosis consultation

+∞

6.9

A04AA01

ATC

ondansetron; systemic, rectal

0.7

6.9

194

2464

A69.2

ICD-10 Finland

Lyme disease

0.6

6.9

147

1967

115

Kela drug reimbursment

Breast cancer

0.7

6.9

252

3057

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

6.9

385

2517

R03DA04

ATC

theophylline; systemic, rectal

1.5

6.9

230

1365

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.9

6.9

441

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.7

6.9

125

635

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

5.6

6.9

D19

ICPC

Teeth/gum symptom/complaint

0.8

6.9

889

9219

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

6.9

102

1473

F90.0

ICD-10 Finland

Disturbance of activity and attention

7.7

6.8

C08CA05

ATC

nifedipine; systemic

1.4

6.8

373

2430

L02BG04

ATC

letrozole; oral

0.7

6.8

161

2109

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.7

6.8

147

785

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

2.1

6.8

297

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

6.8

126

646

HMAK

NOMESCO Finland

0.7

6.8

342

3953

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.8

6.8

104

502

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

6.7

1511

11621

S42.4

ICD-10 Finland

Fracture of lower end of humerus

2.3

6.7

222

SPAT1062

SPAT

Lung clearance therapy

4.4

6.7

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.5

6.7

KMAK

NOMESCO Finland

1.1

6.7

2622

21030

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

26.3

6.7

T93

ICPC

Lipid disorder

0.7

6.7

208

2591

A04AD12

ATC

aprepitant; systemic

0.4

6.7

544

S70.1

ICD-10 Finland

Contusion of thigh

2.1

6.7

293

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

4.0

6.7

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

5.0

6.6

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

17.5

6.6

P80

ICPC

Personality disorder

17.5

6.6

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

17.5

6.6

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.6

6.6

168

938

N32.0

ICD-10 Finland

Bladder-neck obstruction

2.1

6.6

287

C10AA04

ATC

fluvastatin; oral

1.3

6.6

650

4602

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

6.6

627

4420

G24.9

ICD-10 Finland

Dystonia, unspecified

4.5

6.6

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

5.6

6.6

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.6

1170

8815

G44.2

ICD-10 Finland

Tension-type headache

1.3

6.6

554

3849

E000003

ATC

1.5

6.6

198

1152

W18

ICD-10 Finland

Other fall on same level

5.2

6.5

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

5.2

6.5

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

2.1

6.5

312

Z12

ICPC

Relationship problem with partner

3.9

6.5

C08CA01

ATC

amlodipine; oral

1.1

6.5

2635

21171

S06.8

ICD-10 Finland

Other intracranial injuries

6.0

6.5

R06.4

ICD-10 Finland

Hyperventilation

2.4

6.5

197

H47.2

ICD-10 Finland

Optic atrophy

3.4

6.5

S00.3

ICD-10 Finland

Superficial injury of nose

3.0

6.5

110

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.5

2045

16141

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

4.2

6.5

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.8

6.5

109

542

DFF00

NOMESCO Finland

Pure tone audiometry

0.8

6.4

376

4262

D06BB10

ATC

imiquimod; topical

0.6

6.4

130

1759

L03AA14

ATC

lipegfilgrastim; parenteral

0.4

6.4

521

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

6.4

303

1927

K29.2

ICD-10 Finland

Alcoholic gastritis

8.8

6.4

R45.8

ICD-10 Finland

Other symptoms and signs involving emotional state

6.9

6.4

RS122

NOMESCO Finland

6.9

6.4

K88

ICPC

Postural hypotension

2.2

6.4

228

ACC51

NOMESCO Finland

Release of median nerve

0.7

6.4

188

2362

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.7

6.4

140

1859

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.8

6.4

455

RT132

NOMESCO Finland

12.1

6.4

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.0

6.3

334

F63.0

ICD-10 Finland

Pathological gambling

35.1

6.3

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

35.1

6.3

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

35.1

6.3

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

35.1

6.3

OAB95

SPAT

0.3

6.3

348

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

6.3

113

571

S50.0

ICD-10 Finland

Contusion of elbow

1.8

6.3

102

499

K03.66

ICD-10 Finland

Tooth plaque

1.4

6.3

311

1993

AA3AD

NOMESCO Finland

CT of face

3.1

6.3

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.3

1295

9879

M05BA04

ATC

alendronic acid; oral

1.3

6.3

526

3647

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

2.1

6.3

271

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

6.3

1485

11460

R64

ICD-10 Finland

Cachexia

5.3

6.3

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

6.1

6.3

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

1.8

6.3

105

520

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

14.6

6.2

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

3.3

6.2

F43.02

ICD-10 Finland

Acute stress reaction severe

19.7

6.2

R4140

NOMESCO Finland

Psychotherapy

9.6

6.2

G93.0

ICD-10 Finland

Cerebral cysts

4.4

6.2

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

6.6

6.2

S12

ICPC

Insect bite/sting

0.7

6.2

322

3707

S01BC05

ATC

ketorolac; ophthalmic

1.5

6.2

210

1256

A11

ICPC

Chest pain NOS

1.3

6.1

462

3159

RS220

NOMESCO Finland

2.3

6.1

203

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.3

6.1

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.4

6.1

235

1440

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.4

6.1

313

2022

R26

ICD-10 Finland

Abnormalities of gait and mobility

3.7

6.1

Z01.7

ICD-10 Finland

Laboratory examination

1.3

6.1

578

4075

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

1.9

6.1

349

F01.31

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism

61.5

6.1

F34.8

ICD-10 Finland

Other persistent mood [affective] disorders

61.5

6.1

V628A

ICD-9 Finland

Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified

61.5

6.1

XA820

NOMESCO Finland

61.5

6.1

D07AC01

ATC

betamethasone; topical

1.1

6.1

1965

15529

L84

ICD-10 Finland

Corns and callosities

1.5

6.1

183

1064

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

6.1

292

1865

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

811

1161

5.06

322.70

1.2

3.9

3.8

mmol/l

0.85

756

1088

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

816

1129

5.24

307.65

1.3

1.4

337.6

2915.0

e6/l

0.77

665

930

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

800

337

17.30

307.65

1.0

53.3

39.4

ng/l

5.94

584

202

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

789

337

17.05

307.65

1.0

395.4

308.6

ng/l

4.64

586

206

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

799

335

17.38

307.65

1.0

576.9

729.9

ng/l

7.61

576

198

(3019309) Folate [Moles/volume] in Red Blood Cells

6215

20517

2.83

307.65

2.0

1.7

1189.2

1146.7

nmol/l

2.68

4556

15150

(3009466) Valproate [Moles/volume] in Serum or Plasma

644

430

10.79

307.65

4.0

2.7

330.5

331.3

umol/l

0.03

519

354

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

817

1128

5.25

307.65

1.2

1.4

8.9

26.3

e6/l

1.62

646

880

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

913

1336

4.97

307.65

1.2

1.3

506.4

580.7

mg/l

1.36

830

1282

(3044290) Cell count panel - Cerebral spinal fluid

705

1084

4.68

258.42

1.2

1.3

—

(3026008) Bacteria identified in Urine by Culture

6440

31353

1.72

212.87

4.2

3.5

—

(3023368) Bacteria identified in Blood by Culture

5877

28281

1.71

198.71

4.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4585

20715

1.76

192.70

1.8

1.7

437.5

29832598.6

pmol/l

13.17

3620

16385

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9273

77006

0.60

191.49

4.0

4.8

1.4

1.5

mmol/l

5.19

7897

68344

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9462

77841

0.60

180.20

4.0

4.9

4.3

4.4

mmol/l

19.43

8106

69711

(3023410) Appearance of Cerebral spinal fluid

379

470

5.71

174.03

1.3

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6229

31367

1.63

169.05

2.5

3.4

2.3

2.4

mmol/l

2.85

5167

26406

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7734

41084

1.60

168.41

2.5

2.1

89.6

93.5

pmol/l

10.88

4155

20986

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4100

18549

1.72

166.95

3.0

3.1

2.5

mmol/l

5.27

3505

16031

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8993

74427

0.62

166.35

3.6

4.3

1.2

mmol/l

0.42

7556

65323

(40768804) Tissue Pathology biopsy report

3334

34908

0.57

165.29

2.1

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9960

80272

0.62

158.98

4.6

5.6

2.4

2.5

mmol/l

21.87

8580

71613

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1646

5656

2.14

152.63

1.6

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1761

21672

0.51

148.46

1.5

1.6

1.3

mmol/l

0.50

1486

17556

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3717

16873

1.69

146.23

2.0

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

4968

24636

1.58

135.57

1.7

1.6

19.8

20.3

nmol/l

0.96

4344

20563

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2681

11536

1.74

125.43

1.9

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7507

41257

1.50

125.22

3.9

4.5

34.0

34.3

g/l

4.31

6668

37778

(3031040) Bacteria [#/volume] in Urine by Automated count

10119

59303

1.52

122.79

6.7

5.0

3394.1

1217.8

e6/l

2.61

302

958

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2654

11612

1.71

116.00

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9504

75709

0.67

112.64

21.2

17.1

69.0

69.4

ml/min/173m2

1.16

7682

62926

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5437

28490

1.50

109.53

2.5

2.1

274.3

211.9

u/l

5.01

5033

26387

(3012516) Albumin [Mass/volume] in Urine

3124

30306

0.64

96.70

2.8

3.2

568.2

378.5

mg/l

1.19

1970

19179

(3009508) Creatinine [Moles/volume] in Urine

3175

30409

0.65

90.96

2.7

3.1

7.0

6.9

mmol/l

0.47

2452

24797

(3020682) Albumin/Creatinine [Ratio] in Urine

3402

32124

0.66

90.83

3.4

4.0

13.8

9.4

mg/mmol

2.77

2115

20113

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6679

37445

1.41

88.34

5.0

4.2

92.0

73.7

ng/l

0.28

5409

29555

(3016018) Differential panel - Cerebral spinal fluid

309

578

3.76

88.11

1.2

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8332

48639

1.40

86.61

5.7

6.6

1.2

mmol/l

11.91

6749

40508

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1087

4003

1.95

81.50

1.8

1.4

1.7

1.5

3.79

878

3263

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10301

79318

0.71

78.23

4.7

5.3

6.2

6.1

mmol/l

14.12

8791

69929

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

862

2965

2.08

77.92

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7575

44013

1.38

77.01

5.1

5.8

1.2

mmol/l

1.86

6653

39220

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6116

34376

1.38

75.74

2.2

77.6

80.9

nmol/l

13.68

5128

29553

(1761868) Lipid panel - Serum or Plasma

2069

20789

0.64

70.69

3.4

3.5

—

(3028707) Methadone [Presence] in Urine by Screen method

13.77

68.26

2.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9938

76404

0.73

67.07

6.7

6.8

42.6

41.1

mmol/mol

31.73

8663

68681

(3023183) Ammonium ion [Moles/volume] in Plasma

499

1483

2.38

63.94

1.9

28.3

32.9

umol/l

3.93

376

1190

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

954

11320

0.56

63.74

1.2

11.8

17.5

u/ml

1.44

265

3791

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4685

25753

1.37

63.35

2.4

2.3

3.1

mg/l

0.08

3785

21818

(4035726)

636

8465

0.50

62.13

1.3

1.4

—

(3018418) pH of Serum or Plasma

5152

28824

1.36

62.00

3.3

4.0

7.4

0.31

894

5457

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1073

12033

0.59

57.40

1.2

1.3

47.8

41.9

iu/ml

0.43

314

3714

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

220

444

3.47

56.42

2.4

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1574

7153

1.59

55.95

1.7

1.6

—

(3002256) Pathology report gross observation

1113

12296

0.60

55.92

1.4

—

(3019150) Specific gravity of Urine by Refractometry

3456

18550

1.38

52.15

5.5

4.6

1.0

kg/l

0.34

576

3030

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

558

7287

0.51

50.83

1.3

—

(3014271) Vancomycin [Susceptibility]

262

649

2.83

48.23

3.5

2.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

1657

7933

1.50

46.07

3.1

3.0

4.2

4.4

kpa

3.63

1579

7672

(3015736) pH of Urine

5603

32915

1.28

43.02

4.6

3.8

—

5.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

587

2198

1.89

41.47

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

587

2198

1.89

41.47

1.4

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

8639

53720

1.26

40.14

5.0

4.6

7.1

6.9

mmol/l

15.64

8136

50516

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

593

7112

0.56

40.03

1.5

1.6

—

(3003694) ABO and Rh group [Type] in Blood

2219

20149

0.73

39.69

1.3

—

(3026782) Osmolality of Urine

3523

19700

1.31

38.45

3.4

2.9

561.2

547.9

mosm/kgh2o

3.44

2999

16667

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11466

84603

0.78

37.63

10.2

11.4

22.5

23.8

u/l

3.46

10681

80620

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1372

6575

1.49

37.59

1.9

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

108

2461

0.30

37.49

1.5

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5793

34581

1.26

37.33

2.6

2.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

130

245

3.70

36.91

1.2

41.7

64.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1894

9683

1.41

36.78

3.3

3.6

5.8

kpa

1.14

1817

9412

(3029937) Albumin [Presence] in Urine by Test strip

4023

23020

1.29

36.56

5.5

4.5

0.0

estimate

1.54

1050

7397

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5319

31519

1.26

36.18

5.6

4.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

772

3273

1.67

35.78

2.2

941.6

544.6

ug/l

0.74

709

3104

(3002032) Base excess in Venous blood by calculation

1883

9663

1.40

35.70

3.3

3.6

2.1

1.9

mmol/l

1.33

1543

7758

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

120

221

3.79

35.18

3.1

2.7

29.0

28.5

umol/l

0.18

169

(3020191) Ethanol [Moles/volume] in Serum or Plasma

123

239

3.59

33.50

1.3

1.1

1.0

0.6

promille

1.96

102

175

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

227

639

2.49

32.80

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2826

15622

1.31

32.77

29.4

32.6

1.6

1.5

inr

1.54

268

2164

(3012544) pH of Venous blood

1924

10055

1.37

32.49

3.3

3.6

7.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

9479

60241

1.23

32.36

5.7

4.7

—

(3002582) Erythrocytes [#/volume] in Urine

4980

29590

1.25

32.02

4.0

3.4

111.0

122.0

e6/l

0.16

3963

23026

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1563

0.21

30.75

1.4

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

895

9170

0.66

30.73

1.3

511.8

545.2

titre

0.24

191

2187

(3035350) Ketones [Presence] in Urine by Test strip

6768

41671

1.22

30.72

5.0

4.1

0.0

estimate

0.50

1159

7820

(3022145) Colonoscopy Study observation

917

9340

0.66

30.57

1.3

—

(3018095) Leukocytes [#/volume] in Urine

5519

33313

1.23

30.19

4.6

3.9

173.4

131.9

e6/l

1.19

4133

24470

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1326

6584

1.43

30.00

5.3

6.4

24.6

24.5

mmol/l

0.34

1260

6117

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1845

9717

1.36

29.48

2.6

2.4

5.4

6.6

ug/l

2.93

1326

8376

(1001926) Buprenorphine [Presence] in Urine by Screen method

132

4.38

29.38

1.9

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2842

24075

0.78

29.26

2.4

3.0

9113.4

6948.1

umol/l

1.11

2234

20140

(3006270) Folate [Moles/volume] in Blood

265

844

2.20

29.10

1.3

1.2

309.2

312.2

nmol/l

0.08

201

644

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

167

429

2.72

28.95

1.1

—

(3000492) Spirometry study

532

6043

0.60

28.86

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

1498

0.22

28.78

1.2

1.4

—

(3011288) Drugs identified in Urine by Screen method

5.18

28.61

2.2

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1234

11754

0.71

28.50

4.1

5.0

34.3

33.9

0.48

693

7539

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

177

478

2.59

27.89

1.2

2.0

2.3

mmol/l

3.32

161

437

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

660

6989

0.64

26.36

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2400

20534

0.78

26.29

2.9

3.5

0.8

0.9

ug/l

0.17

1701

15232

(3044889) 12 lead EKG panel

7943

60090

0.83

26.26

4.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

16.22

26.01

2.7

2.1

23.0

21.2

umol/l

0.18

(4198724)

11.47

25.96

2.2

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5251

41231

0.82

25.83

4.1

4.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1020

4964

1.46

25.57

4.2

4.1

46.2

45.8

0.22

1011

4898

(3009261) Glucose [Presence] in Urine by Test strip

6788

42310

1.20

25.23

5.1

4.1

0.0

estimate

1.34

1150

7704

(40761535) Cells panel - Urine sediment

1546

8132

1.35

24.66

3.9

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

437

1764

1.74

24.25

1.3

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

3565

20960

1.23

23.72

3.2

2.7

5.5

4.8

e6/l

2.61

3156

18242

(3019060) Gas panel - Arterial blood

1355

7049

1.37

23.14

3.7

4.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

6678

41770

1.19

23.12

6.7

5.5

0.0

estimate

0.50

1141

7851

(4027681)

183

3.43

23.09

1.2

1.3

—

(3021589) Normoblasts [#/volume] in Blood

4642

36604

0.83

23.00

11.0

10.5

0.0

e9/l

1.18

3769

29724

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4524

27319

1.21

22.95

2.4

57.3

61.5

u/l

3.93

4093

24986

(4010399)

591

6177

0.65

22.10

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

109

259

2.93

21.85

2.7

2.0

66.2

56.1

umol/l

1.87

189

(3016879) Cocaine [Presence] in Urine

180

3.29

20.57

1.9

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

408

1695

1.69

20.47

1.2

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

189

3.21

20.24

1.4

1.3

94.0

79.3

umol/l

0.47

107

(40768443) Skin Pathology biopsy report

383

4327

0.60

20.23

1.2

—

(40768797) Stomach Pathology biopsy report

1305

11714

0.75

20.00

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

480

5125

0.64

19.82

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1055

5412

1.38

19.58

3.5

3.3

25.4

25.0

mmol/l

2.19

1023

5266

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11680

84624

0.83

19.52

24.7

21.3

86.2

85.8

umol/l

0.37

11674

84574

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1307

11687

0.76

19.45

2.7

3.9

20.8

23.7

ug/l

0.18

1074

9747

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1208

6339

1.35

19.42

1.8

2.2

404.7

386.3

nmol/l

1.37

1035

5743

(4094501)

136

2074

0.45

19.36

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

651

3093

1.48

18.43

3.3

3.9

mmol/l

0.59

579

2887

(36304419) Bacteria [Presence] in Urine

4226

25791

1.19

18.15

3.9

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

200

2.99

17.97

2.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3296

19714

1.20

17.62

4.5

4.1

197.2

494.9

ng/l

6.26

2932

17361

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

166

3.19

17.59

1.3

49.6

22.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

932

4769

1.38

17.55

2.7

2.4

0.7

1.99

896

4565

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

110

298

2.57

17.42

1.1

37.5

47.9

mg/l

2.01

254

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

889

4526

1.38

17.26

4.1

4.8

1.6

1.5

0.93

851

4250

(3027008) Opiates [Presence] in Urine

205

2.92

17.25

2.0

1.1

—

(40768800) Prostate Pathology biopsy report

195

2524

0.53

17.06

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1194

6373

1.32

17.06

3.4

3.2

126.5

125.8

g/l

0.54

1177

6207

(3028300) Cannabinoids [Presence] in Urine

207

2.89

16.97

2.0

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

733

3621

1.42

16.93

3.2

3.6

1.5

1.4

mmol/l

0.57

717

3543

(3052592) Norovirus Ag [Presence] in Stool

213

2.84

16.67

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.92

16.54

1.1

1.2

24.1

56.4

3.16

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

102

274

2.59

16.45

1.1

263.7

337.8

mg/l

2.58

240

(3003396) Base excess in Arterial blood by calculation

2072

11910

1.24

16.32

4.7

6.2

1.5

1.0

mmol/l

4.35

1565

9215

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

765

7220

0.72

16.28

3.3

2.8

58.4

57.2

ml/min/173m2

0.41

335

3285

(3002179) Metamyelocytes/100 leukocytes in Blood

731

6941

0.72

16.15

3.1

3.7

0.8

0.6

0.47

149

1699

(3007930) Methemoglobin/Hemoglobin.total in Blood

872

4486

1.37

15.88

4.1

4.8

0.9

2.20

837

4205

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2651

15694

1.21

15.56

3.5

3.1

2.5

e6/l

1.72

1535

8972

(3033705) Calcium.ionized [Moles/volume] in Venous blood

370

1612

1.61

15.54

2.9

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3371

20427

1.18

15.25

4.7

4.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2578

15271

1.21

14.98

1.8

1.9

29.8

30.2

2.85

2477

14824

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

880

4577

1.35

14.96

1.8

1.9

3.0

2.3

ug/l

0.56

681

3999

(40768793) Breast Pathology biopsy report

120

1739

0.47

14.93

1.2

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

842

7718

0.74

14.76

3.3

3.9

1.1

0.9

0.47

235

2399

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

866

4509

1.35

14.62

3.0

3.8

24.2

24.1

mmol/l

0.28

775

4037

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

332

3591

0.63

14.57

3.2

4.0

148.5

81.4

u/ml

0.80

314

3451

(3047181) Lactate [Moles/volume] in Blood

631

3120

1.42

14.53

4.6

5.8

1.5

1.3

mmol/l

1.69

566

2778

(3021440) Promyelocytes/100 leukocytes in Blood

797

7344

0.74

14.48

3.3

3.8

0.1

0.08

216

2257

(3040151) Glucose [Moles/volume] in Capillary blood

296

1243

1.66

14.40

9.4

7.7

7.9

7.3

mmol/l

1.69

231

1021

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1774

10156

1.24

14.40

4.9

3.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2049

11912

1.22

14.37

4.7

6.2

11.2

11.9

kpa

7.67

1918

11267

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2050

11921

1.22

14.34

4.7

6.2

5.0

kpa

1.24

1923

11278

(3027944) Amphetamines [Presence] in Urine

200

2.75

14.32

2.1

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

4386

27270

1.16

14.22

3.9

3.3

0.6

0.5

e6/l

0.88

3491

20893

(3003181) Sodium [Moles/volume] in Urine

396

1791

1.55

14.22

1.4

1.3

63.5

62.0

mmol/l

0.35

321

1474

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

163

2104

0.53

14.20

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

116

358

2.26

13.99

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1537

8689

1.25

13.95

4.3

5.8

1.5

1.4

mmol/l

5.79

1451

8343

(3025159) Blasts/100 leukocytes in Blood

739

6794

0.74

13.20

3.3

3.9

0.1

0.5

2.74

176

1883

(3017446) Testosterone [Moles/volume] in Serum or Plasma

516

5010

0.70

13.03

1.9

2.0

10.4

10.8

nmol/l

0.42

416

4203

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

360

2.19

12.69

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

355

2.18

12.36

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1006

5491

1.29

12.17

3.4

2.8

0.4

0.3

e6/l

0.83

992

5386

(3018572) Chloride [Moles/volume] in Blood

470

2277

1.45

12.15

4.9

6.5

104.7

104.9

mmol/l

0.32

436

2036

(3039000) Anion gap in Blood

470

2277

1.45

12.15

4.8

6.5

11.4

11.2

mmol/l

0.41

436

2036

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1297

0.46

12.06

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3436

21206

1.16

11.92

5.1

3.9

—

(3016502) Oxygen saturation in Arterial blood

1830

10720

1.21

11.76

4.8

6.4

94.8

95.4

2.82

1754

10268

(3007164) IgA [Mass/volume] in Serum or Plasma

1510

12555

0.82

11.75

1.5

2.8

2.7

g/l

1.19

754

6929

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2839

22327

0.86

11.69

2.3

2.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

770

4083

1.32

11.53

2.0

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

784

0.33

11.46

1.6

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

437

2118

1.44

11.31

1.2

—

(3016038) Potassium [Moles/volume] in Urine

164

629

1.82

11.07

1.1

34.2

35.7

mmol/l

0.33

131

535

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

195

2233

0.60

11.03

1.9

3.0

231.1

745.4

u/ml

2.35

163

2042

(3000494) Fungus identified in Specimen by Culture

1110

9461

0.80

10.91

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

438

2141

1.43

10.84

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

439

2150

1.43

10.76

1.2

—

(3024731) MCV [Entitic volume]

12120

86616

0.87

10.69

31.2

26.0

91.9

91.8

1.13

11706

84900

(3000963) Hemoglobin [Mass/volume] in Blood

12122

86629

0.87

10.68

31.5

26.3

127.4

131.8

g/l

178.22

11701

84925

(3026361) Erythrocytes [#/volume] in Blood

12121

86620

0.87

10.67

31.3

26.1

4.2

4.4

e12/l

145.77

11538

83351

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

277

2.24

10.65

1.1

—

(3035941) MCH [Entitic mass]

12121

86614

0.87

10.62

31.1

26.0

30.4

2.08

11703

84897

(3007461) Platelets [#/volume] in Blood

12119

86600

0.87

10.61

31.2

26.1

237.8

237.5

e9/l

0.19

11585

83736

(3008037) Lactate [Moles/volume] in Venous blood

540

2750

1.38

10.56

4.1

3.4

1.7

1.6

mmol/l

0.44

534

2684

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

184

2111

0.60

10.51

1.2

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

348

3484

0.69

10.50

1.3

247.0

235.9

u/ml

0.11

311

3166

(3020891) Body temperature

755

4053

1.31

10.38

4.1

4.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

145

1763

0.57

10.37

1.2

11.7

5.5

u/ml

0.36

308

(3008116) Ketones [Moles/volume] in Urine by Test strip

141

2.76

10.37

1.5

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

816

4430

1.29

10.32

2.1

1.9

—

(3010813) Leukocytes [#/volume] in Blood

12129

86630

0.87

10.31

31.3

26.1

7.3

6.9

e9/l

23.52

11548

83391

(3038515) Glucose [Moles/volume] in Venous blood

518

2636

1.38

10.19

4.2

3.5

8.2

7.7

mmol/l

3.00

513

2575

(40768795) Lymph node Pathology biopsy report

920

0.41

10.16

1.1

1.2

—

(3008898) HLA-B27 [Presence]

1258

0.50

10.01

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

145

1745

0.57

10.00

1.2

16.4

5.3

u/ml

0.32

205

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

9.90

7.8

0.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

106

1383

0.53

9.72

1.6

1.5

3.4

3.5

mg/l

0.02

1005

(3013512) EKG study

3862

29415

0.88

9.69

4.9

4.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

5.79

9.65

1.6

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2173

13153

1.17

9.50

2.1

2.3

1.8

0.02

1730

11548

(3010421) pH of Blood

513

2643

1.36

9.38

4.3

4.0

7.4

1.84

425

2254

(3045142) Bone marrow Pathology biopsy report

1192

0.50

9.35

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1079

0.48

9.32

1.4

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

122

1507

0.56

9.29

1.2

1.1

5.7

u/ml

1.87

125

(3008295) Osmolality of Serum or Plasma

195

832

1.63

9.11

1.4

1.3

277.4

274.4

mosm/kgh2o

0.80

137

617

(3007853) Bacteria identified in Skin by Aerobe culture

1745

10412

1.18

9.06

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

164

1850

0.61

8.81

1.2

36.5

44.2

u/ml

0.12

111

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

324

3179

0.70

8.79

1.4

1.6

36.5

38.1

u/l

0.65

254

2646

(1761482) Bacteria [#/volume] in Urine by Culture

610

3268

1.31

8.57

6.0

4.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8950

59346

1.11

8.57

3.8

3.9

15.2

pmol/l

0.56

7746

52149

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

168

704

1.66

8.45

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

117

2.73

8.43

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

117

2.73

8.43

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

181

1974

0.63

8.42

2.6

2.2

210.0

210.1

0.01

167

1867

(3039443) Prostate specific Ag panel - Serum or Plasma

973

0.48

8.37

1.6

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

165

691

1.66

8.33

1.3

1.4

—

(4281824)

911

0.47

8.25

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1626

9733

1.18

8.11

5.0

6.8

119.8

119.2

g/l

0.66

1576

9367

(1616796) Gas panel - Central venous blood

448

2315

1.35

8.09

3.2

3.7

—

(40757373) Influenza virus identified in Isolate

192

2.28

8.02

1.5

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

270

1279

1.47

8.00

2.0

1.8

88.4

89.0

0.86

265

1263

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2719

16927

1.14

7.95

3.2

2.9

1.6

1.4

e6/l

0.51

1591

10130

(3013650) Neutrophils [#/volume] in Blood by Automated count

6628

48621

0.91

7.91

6.9

8.4

4.8

4.4

e9/l

26.13

5665

41852

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

200

2092

0.66

7.68

2.2

2.0

91.3

87.5

1.56

186

1978

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

1488

0.60

7.66

3.4

3.9

444.4

2397.4

iu/ml

1.02

228

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1734

10487

1.17

7.60

3.4

3.1

269.6

269.1

ng/l

0.01

1589

9658

(3025941) Bacteria identified in Stool by Culture

703

3898

1.26

7.58

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1958

11953

1.16

7.57

10.7

8.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

328

1631

1.40

7.52

2.0

1.8

1.9

1.7

mmol/l

1.98

322

1594

(3012501) Base excess in Blood by calculation

442

2307

1.34

7.51

4.4

4.1

2.6

2.7

mmol/l

0.12

319

1559

(3013290) Carbon dioxide [Partial pressure] in Blood

442

2309

1.34

7.46

4.4

4.1

5.1

5.0

kpa

1.24

425

2252

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1057

6137

1.21

7.42

3.2

3.6

2.1

1.9

mmol/l

0.81

753

4503

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

256

2537

0.70

7.42

1.6

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

419

3838

0.75

7.39

2.1

3.2

169.8

2708.0

u/ml

2.72

330

3282

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

192

2004

0.66

7.32

1.5

1.7

13.3

12.2

mg/l

0.74

164

1814

(3002385) Erythrocyte distribution width [Ratio]

8750

63206

0.91

7.25

26.8

21.7

14.1

14.0

8.22

8482

61697

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

658

0.42

7.24

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

10.80

7.17

1.3

1.0

—

(3018010) Neutrophils/100 leukocytes in Blood

5327

39356

0.91

7.09

5.4

5.7

61.2

59.2

24.59

4807

36177

(3027315) Oxygen [Partial pressure] in Blood

441

2322

1.33

7.08

4.4

4.1

8.0

8.4

kpa

6.00

423

2265

(3006315) Basophils [#/volume] in Blood

5662

41707

0.91

7.08

5.0

5.4

0.0

e9/l

2.99

4770

35161

(3013115) Eosinophils [#/volume] in Blood

5832

42888

0.91

7.02

5.2

5.5

0.2

e9/l

0.95

4904

36726

(3001604) Monocytes [#/volume] in Blood

5623

41418

0.91

7.00

5.0

5.4

0.6

e9/l

0.75

4728

34870

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1382

8265

1.18

6.97

1.7

2.0

0.2

g/l

0.43

1183

7645

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

121

1380

0.61

6.91

1.5

1.4

381.1

238.4

pmol/l

0.45

115

1340

(3032080) INR in Blood by Coagulation assay

6424

42182

1.10

6.86

11.8

11.4

1.3

1.4

inr

1.96

1646

11290

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3855

28903

0.90

6.84

4.3

5.1

21.4

22.6

5.70

1904

16209

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

214

2156

0.68

6.83

2.2

1.6

—

(3009343) pH of Capillary blood

1085

6369

1.20

6.79

3.3

3.6

7.4

0.44

135

869

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

109

1267

0.59

6.74

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1072

0.56

6.71

1.4

1.6

52.3

48.8

nmol/l

0.54

1011

(3006504) Eosinophils/100 leukocytes in Blood

5316

39205

0.91

6.70

5.3

5.7

2.7

2.8

2.00

4797

36000

(3028026) IgM [Mass/volume] in Serum or Plasma

509

4482

0.78

6.68

1.8

1.5

1.4

g/l

0.30

425

3975

(3019069) Monocytes/100 leukocytes in Blood

5345

39394

0.91

6.63

5.6

6.0

8.9

9.0

1.12

4834

36274

(40760892) CBC W Ordered Manual Differential panel - Blood

2068

16045

0.88

6.62

4.2

4.6

—

(3004616) Nuclear Ab [Presence] in Serum

968

0.54

6.59

1.1

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

453

4036

0.77

6.54

1.3

1.5

35.8

19.5

u/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

165

2.23

6.50

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

471

2536

1.30

6.47

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.31

6.45

1.1

1.0

—

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

4.31

6.45

1.1

1.0

—

mmol/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

388

3521

0.76

6.44

1.2

1.1

89.1

125.3

iu/ml

1.18

126

1184

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4889

36149

0.91

6.44

4.6

5.9

6.1

4.7

ug/l

0.53

4090

31834

(3042111) Morphology [Interpretation] in Bone marrow Narrative

189

1925

0.68

6.42

1.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1093

6463

1.19

6.32

3.3

3.6

5.2

5.1

kpa

3.66

955

5918

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

232

2268

0.71

6.28

2.6

2.1

3.6

3.7

g/l

0.42

217

2150

(3022096) Basophils/100 leukocytes in Blood

5184

38190

0.91

6.26

5.3

5.7

0.6

10.74

4678

35111

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

339

3116

0.75

6.19

1.6

166.3

260.6

titre

0.65

157

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

278

2630

0.73

6.17

1.6

1.4

19.0

15.5

iu/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

273

2589

0.73

6.15

1.2

0.5

1.1

u/ml

1.72

265

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

183

2.13

6.14

1.1

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

900

7394

0.84

6.11

1.8

2.0

193.5

165.5

ug/g

0.99

650

5623

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

188

2.11

6.11

1.6

1.2

96.5

140.9

nmol/l

1.77

142

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1395

8441

1.16

6.07

3.5

3.7

1.2

mmol/l

0.04

1134

7278

(3002030) Lymphocytes/100 leukocytes in Blood

5451

40026

0.92

6.06

5.6

5.9

23.6

25.4

25.03

4890

36603

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

803

0.53

5.95

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1627

12734

0.87

5.92

2.7

4.0

247.6

251.6

u/l

0.44

1427

11984

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

182

2.10

5.86

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

126

1365

0.64

5.83

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

419

0.36

5.70

1.1

—

(3045414) Leukocytes [Presence] in Urine

457

3994

0.79

5.69

2.3

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

5794

42350

0.92

5.67

5.2

5.5

1.7

1.9

e9/l

2.97

4891

36365

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

136

1436

0.65

5.60

1.5

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

832

0.55

5.60

1.6

1.8

4.5

4.7

mg/l

0.16

787

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

181

2.07

5.59

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

405

2183

1.29

5.58

4.1

3.7

31.8

30.1

mg/l

0.37

311

1431

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7045

46718

1.08

5.57

4.3

6.0

12.5

12.4

umol/l

0.12

6446

44277

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

102

1138

0.62

5.41

1.9

2.1

1077.7

1278.1

u/ml

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

179

2.06

5.39

1.1

—

(21494434) Karyotype in Bone marrow

1013

0.60

5.33

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

854

0.57

5.31

1.1

1.6

g/l

0.45

755

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5138

33686

1.09

5.28

2.8

2.9

147.5

161.9

ug/l

3.30

4395

30210

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

304

1.78

5.24

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

304

1.78

5.24

2.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

141

1448

0.67

5.09

1.5

1.8

18.6

23.6

ug/l

1.60

135

1408

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

193

942

1.43

5.07

2.5

2.2

2.3

u/field

0.09

320

(3021879) Hepatitis B virus core Ab [Presence] in Serum

422

3669

0.79

5.06

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

728

5981

0.84

4.99

1.4

—

(3036603) Volume of Urine

626

0.52

4.85

2.1

1.5

1704.2

1853.2

0.35

177

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

532

0.48

4.82

1.2

1.1

0.3

1.9

u/ml

2.61

199

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1028

0.63

4.80

1.2

1.3

0.3

0.4

nmol/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

179

1737

0.71

4.75

1.2

1.3

44.9

41.2

u/l

0.14

150

1487

(42529582) MDA5 Ab [Presence] in Serum by Line blot

214

0.29

4.74

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

214

0.29

4.74

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

214

0.29

4.74

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

214

0.29

4.74

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

685

5626

0.84

4.70

2.6

2.7

10.6

10.7

g/l

0.13

586

5125

(40767503) Oxygen content in Capillary blood by calculation

407

2248

1.26

4.69

2.5

16.1

15.7

1.04

185

1233

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1021

0.63

4.67

1.2

1.3

0.6

1.9

nmol/l

0.63

972

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.71

4.66

1.1

—

(3022621) pH of Urine by Test strip

1029

6214

1.16

4.64

4.4

3.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.09

4.63

1.1

1.3

51.1

32.2

0.90

(3027456) Digoxin [Moles/volume] in Serum or Plasma

542

3097

1.22

4.60

3.7

3.2

0.8

nmol/l

0.07

408

2426

(3014576) Chloride [Moles/volume] in Serum or Plasma

2041

12887

1.11

4.59

4.8

6.1

104.5

104.4

mmol/l

0.44

1963

12584

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

125

1285

0.67

4.59

2.6

3.6

31.2

49.2

u/ml

1.54

116

1243

(1617658) Protocol used for examination of sentinel lymph nodes

593

0.53

4.52

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

952

0.62

4.49

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

107

1129

0.66

4.48

2.8

3.6

60.6

59.6

0.14

696

(3028717) Thiamine [Mass/volume] in Blood

2.83

4.43

1.0

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

235

2161

0.75

4.43

1.9

1.5

1.1

g/l

0.14

218

2037

(3044242) Glucose [Moles/volume] in Arterial blood

113

510

1.54

4.42

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

247

0.28

4.41

1.1

1.4

—

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

12065

85287

0.92

4.39

26.7

21.4

4.0

mmol/l

1.98

11597

82873

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1272

7830

1.14

4.38

2.9

3.7

92.5

98.8

ng/l

1.57

978

6547

(4034850)

469

2655

1.23

4.37

12.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

240

1.80

4.33

1.1

u/l

0.36

117

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

310

2735

0.78

4.27

1.1

1.8

1.0

u/ml

—

(40768441) Liver Pathology biopsy report

513

0.51

4.16

1.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

290

1.70

4.15

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

727

0.59

4.14

1.3

1.2

7.5

7.9

mmol/l

0.63

475

(3024980) IgG subclass 4 [Mass/volume] in Serum

1042

0.66

4.13

1.4

1.6

0.8

0.9

g/l

0.16

773

(3015235) Bicarbonate [Moles/volume] in Capillary blood

493

2825

1.22

4.11

2.7

3.1

25.1

24.9

mmol/l

0.66

445

2456

(3019550) Sodium [Moles/volume] in Serum or Plasma

12058

85181

0.92

4.10

26.7

21.2

139.6

139.5

mmol/l

1.55

11616

82904

(3037556) Urate [Mass/volume] in Serum or Plasma

337

0.41

4.03

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.40

4.03

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

236

1.77

4.01

1.5

1.7

—

(3042631) Mycobacterium sp identified in Specimen

171

1617

0.73

3.94

2.3

2.7

—

(3045424) Erythrocytes [Presence] in Urine

156

1496

0.72

3.93

1.6

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1863

14117

0.90

3.87

1.2

1.8

1.9

u/ml

0.09

418

3315

(3009214) Lutropin [Units/volume] in Serum or Plasma

900

0.65

3.85

1.3

14.2

12.8

u/l

0.30

721

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

233

2100

0.77

3.85

1.8

1.4

0.2

g/l

0.04

215

1973

(3010726) Horse dander IgE Ab [Units/volume] in Serum

359

0.44

3.84

1.0

0.2

0.9

u/ml

—

(3044640) Blood type and Crossmatch panel - Blood

3996

29291

0.93

3.83

2.4

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

348

0.44

3.81

1.5

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

442

0.50

3.79

1.0

0.4

0.8

u/ml

—

179

(40761511) CBC panel - Blood by Automated count

11512

81403

0.93

3.79

21.5

17.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

289

2531

0.79

3.79

1.8

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11818

80472

1.08

3.75

22.6

17.4

31.1

27.8

mg/l

17.57

10366

66010

(3047189) Immunofixation for 24 hour Urine

557

0.56

3.73

1.3

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

275

0.38

3.71

1.0

1.1

0.2

1.9

u/ml

—

104

(3003888) Timothy IgE Ab [Units/volume] in Serum

456

0.52

3.69

1.0

1.2

4.0

u/ml

1.54

202

(3014133) Dog dander IgE Ab [Units/volume] in Serum

294

0.40

3.68

1.0

1.1

0.2

1.8

u/ml

—

112

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

2.03

3.67

3.6

2.7

0.4

0.5

u/field

0.24

123

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

700

0.61

3.61

1.0

1.1

113.2

115.7

0.26

607

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

281

0.39

3.60

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

707

0.62

3.58

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

916

0.66

3.54

1.1

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

200

1817

0.76

3.54

3.3

3.6

2.1

1.4

1.00

150

1377

(3024471) HLA-A [Type]

136

0.25

3.48

1.0

—

(4306422)

718

0.63

3.46

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

122

1189

0.71

3.44

1.2

47.4

45.4

u/ml

0.04

141

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

471

3879

0.84

3.43

2.5

2.7

—

(42870588) Differential panel, method unspecified - Blood

4092

29850

0.93

3.35

4.7

5.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.47

3.35

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

329

0.46

3.33

2.8

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

135

0.26

3.32

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

246

2156

0.79

3.30

2.7

2.4

—

(3023419) Bacteria identified in Sputum by Culture

140

1324

0.73

3.30

1.8

2.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

741

0.64

3.26

1.6

1.7

160.6

190.0

pmol/l

2.13

679

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

102

484

1.47

3.26

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

424

2459

1.20

3.21

2.1

2.2

126.5

125.8

g/l

0.19

343

1805

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

122

1169

0.72

3.14

1.2

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

315

2669

0.82

3.13

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

102

1005

0.70

3.11

1.1

1.4

56.8

58.3

mu/l

0.03

885

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

732

0.65

3.10

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

102

1004

0.70

3.10

1.2

1.3

110.8

122.6

u/ml

0.66

228

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

127

0.27

3.05

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

240

0.40

3.03

1.0

1.1

—

5.6

—

(40765096) Chromosome analysis panel by Banding

317

0.48

3.03

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

426

0.55

3.02

1.1

—

(1002224) Polysomnography panel

149

1372

0.75

2.97

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

598

0.63

2.97

1.0

1.1

3.9

u/ml

—

148

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

216

1.67

2.97

1.3

1.4

16.6

17.4

pmol/l

0.33

177

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

624

3766

1.16

2.96

3.8

4.0

25.1

24.8

mmol/l

1.34

517

3414

(3039162) Centromere protein B Ab [Units/volume] in Serum

813

0.68

2.92

1.3

1.2

34.3

52.1

u/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

552

0.61

2.91

1.0

1.1

93.7

92.8

0.09

505

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

1.73

2.89

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.40

2.89

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

2.86

0.0

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

147

0.33

2.86

3.6

2.6

123.9

1400.1

u/l

—

141

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

111

1.94

2.85

1.2

1.1

—

(44813793)

391

0.55

2.84

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

134

1243

0.75

2.83

1.5

70.8

62.7

1.97

784

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

362

1.50

2.83

1.1

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

946

0.71

2.83

1.1

1.3

259.8

258.7

pmol/l

0.01

716

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.36

2.79

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

120

0.29

2.76

1.6

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1206

7620

1.11

2.74

2.3

32.3

50.0

u/l

1.19

982

6480

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

132

0.32

2.74

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

132

0.32

2.74

1.3

1.4

—

(3017509) Phencyclidine [Presence] in Urine

6.94

2.73

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

133

0.31

2.73

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

133

0.31

2.73

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

181

975

1.29

2.72

2.7

2.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

113

1.91

2.72

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

131

1210

0.75

2.71

1.8

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

438

0.59

2.71

2.0

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

356

2934

0.84

2.69

1.1

—

(3021788) Differential panel - Synovial fluid

203

1770

0.79

2.68

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

284

0.49

2.68

2.9

1.8

—

(3017732) Neutrophils [#/volume] in Blood

702

5496

0.88

2.67

3.5

3.2

4.3

e9/l

0.28

431

3831

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

259

1460

1.23

2.67

1.7

1.6

—

(3024928) Oxygen saturation in Venous blood

343

1989

1.20

2.67

2.5

2.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

581

0.64

2.65

2.1

2.2

502.2

102.0

ug/min

0.40

145

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

309

0.52

2.62

2.0

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

128

0.32

2.60

1.2

1.0

—

(3025130) Human papilloma virus identified in Specimen

424

0.59

2.60

1.8

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

136

1241

0.76

2.59

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

140

0.35

2.59

1.3

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

744

0.69

2.59

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

104

986

0.73

2.58

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

714

5569

0.88

2.57

1.4

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

889

0.72

2.57

1.2

1.3

—

nmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

146

1.76

2.57

2.7

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

247

2096

0.81

2.56

1.6

42.6

5.7

iu/ml

1.02

520

(3026470) Cobalt [Mass/volume] in Blood

799

0.70

2.56

1.7

1.9

2.8

4.2

ug/l

1.52

699

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

2.51

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

812

0.71

2.51

1.1

1.2

2.8

5.0

u/ml

0.77

267

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

295

0.52

2.50

1.7

1.5

1534.6

17049.4

e6/l

1.58

165

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

2.49

0.0

3.6

—

(3022689) Creatine [Moles/volume] in Urine

256

0.49

2.45

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

329

0.55

2.45

1.7

445.4

5203.1

e6/l

1.02

224

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

460

0.62

2.45

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

459

0.62

2.43

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

459

0.62

2.43

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

659

5142

0.88

2.41

1.2

—

(3021901) Oxygen saturation in Capillary blood

367

2164

1.18

2.41

2.4

2.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

418

2492

1.17

2.40

2.5

2.9

7.5

7.8

kpa

2.74

393

2295

(3014891) Appearance of Pleural fluid

203

1.61

2.38

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

456

0.62

2.37

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

199

1711

0.80

2.37

1.1

1.2

672.0

864.6

titre

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

506

0.64

2.35

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

455

0.62

2.35

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

455

0.62

2.35

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

143

0.39

2.35

10.5

12.2

5.5

5.0

mmol/l

—

143

(3000991) Gas panel - Venous blood

1314

8405

1.09

2.35

4.9

7.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

169

924

1.27

2.32

1.8

1.6

28.2

25.2

u/ml

0.39

182

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

2.30

0.0

1.8

—

203.7

—

(3036489) Thrombin time

347

2821

0.85

2.29

1.9

1.8

21.8

22.1

0.25

320

2557

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

781

0.72

2.28

1.1

1.2

4.0

4.2

u/ml

0.05

338

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.70

2.27

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

273

1.50

2.24

1.1

78.0

490.3

ng/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

158

1.67

2.24

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.43

2.22

1.6

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

121

1091

0.77

2.17

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.31

2.16

1.0

—

(3011412) CD3 cells [#/volume] in Blood

700

0.71

2.15

2.5

1.9

1.0

e9/l

0.13

438

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

146

0.43

2.12

1.1

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

5.78

2.12

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6596

44546

1.05

2.11

3.3

2.9

55.6

55.7

u/l

0.03

5761

39882

(3038071) Oxygen [Partial pressure] in Mixed venous blood

195

0.46

2.10

5.8

8.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

591

0.69

2.10

1.1

1.2

104.5

137.3

titre

0.51

113

(3012565) Volume of 24 hour Urine

433

0.64

2.09

1.8

2.1

1697.4

1802.8

0.21

358

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

161

1394

0.80

2.09

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

167

1.62

2.08

1.1

1636.1

1628.5

miu/ml

0.01

167

(3019420) Tryptase [Mass/volume] in Serum or Plasma

276

0.55

2.07

1.8

1.6

10.7

11.0

ug/l

0.04

247

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

116

0.36

2.06

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

211

0.49

2.03

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

852

0.75

2.03

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

201

1694

0.82

2.03

1.1

83.3

144.2

titre

1.50

124

(3050129) First trimester maternal screen panel - Serum or Plasma

163

0.43

2.02

1.6

1.5

—

(4268621)

512

0.68

2.01

2.1

2.3

—

(3025577) Chromium [Mass/volume] in Blood

769

0.74

1.98

1.8

2.0

1.7

2.3

ug/l

1.19

644

(3022313) Gas panel - Capillary blood

724

4541

1.11

1.98

3.5

3.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

911

0.76

1.97

1.0

1.2

288.9

283.2

u/ml

0.07

528

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

235

0.53

1.95

5.9

8.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

1.94

0.0

2.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

456

0.67

1.90

1.0

1.1

—

(3019977) pH of Arterial blood

117

629

1.29

1.90

2.3

2.2

7.4

0.22

244

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2281

15022

1.06

1.89

2.3

2.8

0.8

mmol/l

0.39

1980

13796

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.81

1.89

1.2

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

118

0.41

1.83

2.6

1.5

60.7

61.4

pmol/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

435

0.67

1.82

5.5

6.0

—

(4146454)

136

1178

0.80

1.82

2.5

2.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

165

0.46

1.82

1.1

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

630

0.73

1.82

1.5

1.4

44.3

34.3

iu/l

1.25

535

(3022948) Iron [Moles/volume] in Serum or Plasma

2460

16260

1.06

1.81

2.2

2.5

10.8

11.9

umol/l

10.35

2118

14918

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9818

67026

1.04

1.81

6.1

7.6

82.7

82.0

u/l

0.44

8923

62591

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

669

0.74

1.80

1.2

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.26

1.80

1.3

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.06

1.79

1.8

1.5

1.2

1.3

mmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

390

0.66

1.76

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

179

1022

1.22

1.76

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

322

0.62

1.75

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

224

1308

1.19

1.74

5.5

6.0

13.0

12.5

mg/l

0.93

195

1177

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5125

34546

1.04

1.71

3.1

3.2

2345.5

1944.4

ng/l

5.51

4303

30296

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

328

0.63

1.70

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

627

3941

1.11

1.69

2.8

3.2

4.3

pmol/l

0.61

504

3428

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

223

0.56

1.67

3.3

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

106

0.39

1.67

1.3

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.36

1.65

1.0

—

0.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

135

754

1.24

1.65

1.2

1.3

201.7

367.2

titre

0.65

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

167

0.50

1.63

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

312

1.38

1.61

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

551

0.73

1.59

4.3

5.1

87.4

133.0

u/ml

0.27

164

(3034891) Synovial lining cells/100 cells in Synovial fluid

470

0.71

1.58

1.3

1.5

4.2

4.1

0.02

118

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

196

1610

0.84

1.57

2.7

3.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

637

0.75

1.57

1.1

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

304

0.64

1.56

1.0

1.1

13.8

12.4

iu/ml

—

(3005033) Fetal Nuchal fold Thickness US

101

0.41

1.56

1.3

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

131

735

1.24

1.56

1.3

28.6

66.9

titre

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

102

0.41

1.55

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

274

2189

0.87

1.55

2.2

2.6

1.8

mg/l

0.05

226

1922

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

154

0.50

1.53

6.5

7.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.68

1.53

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.38

1.53

1.0

1.4

—

(3051651) Icteric interference index of Serum or Plasma

106

582

1.27

1.52

3.3

4.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

533

1.28

1.52

2.6

2.0

2.1

2.5

u/field

0.30

351

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1449

9482

1.07

1.51

2.1

2.6

10.2

10.1

umol/l

0.05

1180

8323

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

617

0.75

1.51

3.0

3.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

648

0.76

1.50

1.3

1.4

2.8

2.9

g/l

0.31

447

(3027135) IgG subclass 1 [Mass/volume] in Serum

648

0.76

1.50

1.3

1.4

7.3

7.1

g/l

0.14

442

(3024139) IgG subclass 3 [Mass/volume] in Serum

648

0.76

1.50

1.3

1.4

0.5

g/l

0.02

446

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.50

1.49

1.0

—

31.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

880

5661

1.08

1.48

4.7

6.0

25.0

24.7

mmol/l

1.58

864

5605

(21494815) CD4 cells/100 lymphocytes in Specimen

567

0.75

1.47

2.2

1.9

50.1

38.8

—

(3048879) Bone marrow aspiration report

390

0.69

1.47

1.2

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

107

924

0.80

1.46

1.6

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

337

2640

0.88

1.44

1.1

276.3

222.9

titre

0.15

(3000475) Leukocytes [#/volume] in Synovial fluid

298

2349

0.88

1.41

1.6

22821.6

13944.4

e6/l

1.29

214

1681

(4015189)

279

0.65

1.40

1.8

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.70

1.39

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

529

0.75

1.38

2.2

1.8

15.4

16.1

0.12

184

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

118

1001

0.82

1.38

1.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

8850

62333

0.97

1.35

3.9

4.4

16.4

15.2

mm/h

8.78

7788

56550

(3045788) Cell count panel - Pleural fluid

162

1331

0.84

1.35

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

106

0.46

1.34

1.0

1.1

—

11.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1283

9427

0.94

1.34

4.4

6.0

12.0

11.8

mmol/l

0.28

1151

8844

(4062490)

644

0.77

1.34

1.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

207

0.60

1.32

1.3

1.4

121.3

128.8

ng/l

0.12

207

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

501

0.75

1.32

1.1

33.3

28.4

u/l

0.26

365

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

1.31

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

160

1312

0.84

1.31

1.2

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

500

0.75

1.30

1.1

85.5

89.4

u/l

0.14

375

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.60

1.30

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

110

932

0.82

1.29

1.1

83.9

521.1

iu/ml

0.77

161

(3023520) Reticulocytes [#/volume] in Blood

1524

10046

1.06

1.28

2.2

2.5

65.2

67.1

e9/l

1.30

1153

7712

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

177

1436

0.85

1.28

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

568

0.77

1.26

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

568

0.77

1.26

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

360

2780

0.90

1.25

1.8

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

160

0.56

1.24

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

480

0.75

1.24

5.0

3.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10657

73116

1.04

1.23

5.0

4.8

2.0

2.1

mu/l

2.78

9386

64597

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

463

1.26

1.23

1.9

2.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

414

0.74

1.20

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

540

0.77

1.20

2.2

1.8

72.5

69.6

0.62

511

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3538

23829

1.04

1.20

2.8

3.1

34.7

36.3

u/l

0.57

3240

22340

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

808

0.81

1.18

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

808

0.81

1.18

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

808

0.81

1.18

1.2

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

783

5817

0.93

1.17

2.5

2.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

119

988

0.83

1.16

1.1

1.2

62.9

62.5

u/l

0.02

649

(3003338) MCHC [Mass/volume]

9053

61981

1.03

1.15

29.3

23.9

329.9

330.8

g/l

15.41

8817

61399

(40768806) Pleura Pathology biopsy report

188

1502

0.87

1.14

1.5

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.57

1.14

1.5

1.8

42.2

45.2

umol/l

0.23

(4211845)

520

0.77

1.14

4.8

3.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

472

0.76

1.13

2.3

2.1

528.0

553.3

e6/l

0.10

210

(3025549) Creatine [Moles/time] in 24 hour Urine

1.63

1.12

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

482

1.24

1.11

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

482

1.24

1.11

1.2

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

143

843

1.18

1.11

1.3

1.5

—

(4024509)

125

1026

0.84

1.09

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

112

928

0.84

1.08

1.4

1.5

18.2

27.3

3.23

585

(40768446) Kidney Pathology biopsy report

220

0.66

1.07

1.0

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

178

0.62

1.07

2.9

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

380

0.75

1.05

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

381

2900

0.91

1.05

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

505

0.78

1.04

2.4

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

284

0.71

1.04

1.6

1.4

0.1

0.2

nmol/l

0.64

206

(3052851) Hemolysis interference index of Serum or Plasma

473

3019

1.09

1.04

3.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.59

1.04

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.11

1.03

1.0

—

(3044007) Cell count panel - Peritoneal fluid

267

0.70

1.03

2.0

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

226

0.67

1.03

3.5

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

146

1176

0.86

1.02

4.2

3.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

181

1435

0.87

1.02

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

223

1.34

1.02

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

394

2497

1.10

1.02

1.4

267.8

255.8

ug/g

0.57

210

1554

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

124

0.56

1.02

1.0

—

(40761536) Microorganisms panel - Urine sediment

1132

7460

1.06

1.01

5.7

4.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.86

1.01

1.0

—

(3015183) Erythrocyte sedimentation rate

175

0.63

1.00

1.1

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.93

1.00

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

1.00

0.0

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.51

1.00

1.6

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1195

7893

1.05

0.99

2.0

2.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

100

828

0.84

0.99

1.1

1.2

—

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

182

0.65

0.98

2.1

1.6

9.6

9.8

ug/l

0.06

182

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

254

1964

0.90

0.97

1.4

1.5

29.8

31.4

g/l

1.28

230

1743

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

1350

0.88

0.93

1.2

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

776

0.84

0.91

1.0

1.1

—

11.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

410

0.78

0.91

1.1

—

(3012441) Differential panel - Pleural fluid

191

1495

0.89

0.91

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

660

4879

0.94

0.91

2.6

2.9

—

(3000330) Specific gravity of Urine by Test strip

849

5570

1.06

0.91

5.2

3.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

201

1568

0.89

0.91

1.4

1.5

59741.8

60368.4

e6/l

0.01

129

905

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

145

0.62

0.90

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

107

0.58

0.90

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

110

0.57

0.90

1.3

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

110

0.57

0.90

1.0

2.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

307

0.75

0.90

2.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

168

1324

0.88

0.90

1.2

1.3

368.6

438.2

u/l

0.42

156

1257

(3027035) Albumin [Mass/time] in 24 hour Urine

0.53

0.90

1.6

1.3

—

878.3

—

(3020650) Glucose [Presence] in Urine

177

0.67

0.88

3.1

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

161

1269

0.88

0.87

1.5

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

190

1482

0.89

0.87

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

404

1.22

0.86

1.2

1.3

1.2

nmol/l

0.01

313

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.51

0.84

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

271

0.74

0.83

1.1

ratio

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

256

1.27

0.83

1.5

1.6

6.0

4.2

nmol/l

0.20

217

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

141

0.64

0.82

1.8

4.4

35.8

42.8

u/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

286

0.75

0.82

7.5

2.8

49.7

48.4

u/ml

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.81

0.0

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.81

0.0

1.7

—

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.81

0.0

1.1

—

8.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

363

0.78

0.80

1.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

363

0.78

0.80

1.2

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.50

0.80

2.2

4.7

—

(3000034) Microalbumin [Mass/volume] in Urine

114

913

0.87

0.80

2.6

3.1

58.8

40.7

mg/l

0.38

669

(3003327) Ova and parasites identified in Stool by Light microscopy

256

1951

0.91

0.79

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

252

0.74

0.78

1.2

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

338

0.78

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

338

0.78

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

365

1.22

0.77

1.9

1.6

2543.6

1100.2

u/l

0.31

134

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

147

0.66

0.77

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

140

1102

0.88

0.77

3.1

3.5

—

(40758558) Short blood count panel - Blood

2988

21235

0.97

0.76

5.9

6.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

213

1634

0.90

0.76

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

112

674

1.15

0.75

8.4

13.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

154

0.68

0.75

1.1

1.2

—

1488.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

162

1260

0.89

0.74

1.3

1.4

6.1

6.4

mmol/l

0.62

146

1168

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

178

0.70

0.74

1.1

1.3

109.0

113.5

0.26

157

(3025315) Body weight

0.54

0.74

7.7

5.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

137

0.66

0.74

1.0

1.4

—

9.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

748

5462

0.95

0.73

5.8

7.6

24.4

24.3

mmol/l

0.25

661

5042

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

358

0.79

0.73

2.0

1.9

1104.6

1732.8

u/ml

1.26

348

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

495

0.83

0.73

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

186

1433

0.90

0.72

1.3

1.2

—

(3034426) Prothrombin time (PT)

169

0.70

0.72

1.1

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

121

1.38

0.72

2.3

1.9

2424.0

1571.7

e6/l

0.13

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

486

0.83

0.71

1.1

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

486

0.83

0.71

1.1

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

486

0.83

0.71

1.1

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

232

0.75

0.71

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.51

0.70

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.51

0.70

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.51

0.70

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.73

0.70

1.9

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

209

1315

1.10

0.70

1.3

1.4

—

(4133840)

135

0.67

0.69

1.6

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

597

0.85

0.69

1.2

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

110

0.63

0.69

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

226

1.26

0.69

1.1

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

189

1.29

0.69

1.3

1.4

21.8

22.3

0.03

149

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

589

0.85

0.69

1.6

1.5

4.5

7.5

u/l

1.23

275

(3018133) Calcium [Moles/volume] in Urine

0.57

0.69

1.1

1.6

2.3

2.6

mmol/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

9690

67807

0.98

0.69

24.6

19.4

36.3

37.8

22.29

4983

39964

(3029075) Extractable nuclear Ab panel - Serum

183

0.72

0.68

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.53

0.68

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

105

1.39

0.67

1.5

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

111

1.38

0.67

3.2

6.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.53

0.65

1.2

1.1

0.9

1.1

u/field

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

458

0.83

0.65

1.4

2.6

2.2

0.16

377

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

367

0.81

0.65

1.3

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

175

1097

1.11

0.65

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

407

3010

0.94

0.64

1.9

2.3

0.0

g/l

0.00

339

2735

(3050794) Legionella sp Ab [Presence] in Serum

0.59

0.63

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.59

0.63

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

289

0.79

0.63

1.2

1.3

46.5

34.6

u/l

0.75

240

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.56

0.63

1.3

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

102

620

1.14

0.63

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

426

1.17

0.63

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

327

0.81

0.62

1.1

1.5

20.4

12.5

umol/l

0.23

229

(3013166) Neutrophils/100 leukocytes in Synovial fluid

305

1.21

0.62

1.2

1.4

76.5

61.3

3.85

263

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

115

0.66

0.62

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.62

0.0

4.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.62

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.61

0.0

8.5

—

39.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1921

12977

1.03

0.60

3.9

5.2

1.0

mmol/l

0.33

1660

11859

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.56

0.60

2.1

1.3

1.2

1.1

u/field

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

423

0.84

0.59

2.4

2.1

0.2

e9/l

1.00

380

(3006922) Hepatitis E virus Ab [Presence] in Serum

370

0.82

0.59

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

661

0.87

0.59

3.4

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

594

0.86

0.59

1.2

1.5

—

(3044927) Protein electrophoresis panel - Urine

197

1251

1.09

0.58

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

601

0.87

0.58

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

200

0.76

0.57

1.4

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.45

0.57

1.1

1.3

0.1

g/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.55

0.57

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

555

0.86

0.57

1.2

115.6

91.4

u/l

0.62

481

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.67

0.56

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

337

0.82

0.56

4.6

5.7

56.1

73.0

2.27

264

(3020876) Protein [Mass/time] in 24 hour Urine

119

921

0.90

0.55

1.6

1.9

1.3

0.8

g/24h

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

486

0.86

0.55

1.1

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

206

0.77

0.54

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

290

0.81

0.54

1.5

1.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.37

0.53

12.4

11.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.45

0.53

1.0

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.60

0.53

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.59

0.53

1.2

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

100

617

1.13

0.52

1.5

—

2.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

393

0.85

0.51

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

445

0.86

0.51

2.3

2.0

406.8

489.7

e6/l

0.83

381

(3037121) Protein [Mass/volume] in Urine

518

3426

1.05

0.50

2.4

2.8

0.4

0.3

g/l

0.45

175

1410

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

519

0.87

0.50

1.2

11.0

12.0

mmol/l

0.35

152

(3006245) CD3-CD19+ cells/100 cells in Blood

205

1.22

0.50

2.0

1.9

9.2

11.9

0.34

180

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

139

1059

0.91

0.50

1.2

1.3

20.5

12.6

u/l

1.08

120

972

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

392

0.85

0.50

1.2

1.3

—

(3016750) Collection duration of Urine

614

0.88

0.50

2.0

509.0

497.2

min

0.40

432

(3013727) Leukocytes other/100 leukocytes in Blood

372

1.16

0.49

4.3

3.6

54.1

53.8

0.03

351

(3033923) Metanephrine [Moles/time] in 24 hour Urine

179

0.77

0.48

1.1

0.6

0.7

umol/24h

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

321

1.17

0.48

2.0

1.8

13.6

14.4

nmol/l

0.35

297

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

338

2215

1.06

0.47

1.3

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

119

748

1.10

0.47

2.1

1.8

363.6

306.6

mu/l

0.65

110

692

(3020491) Glucose [Moles/volume] in Blood

104

649

1.11

0.47

2.1

2.2

7.5

7.2

mmol/l

0.37

432

(3033799) Differential panel - Peritoneal fluid

277

0.83

0.47

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

1.22

0.46

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

107

0.71

0.46

1.0

1.1

3.6

21.2

iu/ml

—

(40762814) Titanium [Mass/volume] in Blood

223

0.81

0.45

1.9

2.1

3.2

3.3

ug/l

0.11

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

168

1076

1.08

0.45

1.3

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

352

2576

0.95

0.45

2.0

2.3

118.6

99.5

ug/min

0.28

177

1476

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.41

0.44

1.1

12.2

8.5

u/l

0.66

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.39

0.44

2.1

1.8

7.0

11.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2231

15182

1.02

0.44

2.2

2.5

2.2

g/l

6.58

1928

13938

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

420

3057

0.95

0.44

1.9

2.3

0.0

g/l

0.08

339

2745

(3042936) Bacteria identified in Isolate by Culture

1862

13197

0.98

0.44

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

177

1.22

0.43

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.42

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.42

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.42

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

231

1706

0.94

0.41

1.3

1.5

3345.9

1735.7

e6/l

1.00

174

1217

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

204

0.82

0.40

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

537

0.89

0.40

1.2

41.0

26.3

u/l

0.85

456

(3020630) Protein [Mass/volume] in Serum or Plasma

1396

9467

1.03

0.39

2.0

2.6

65.0

65.9

g/l

3.47

1147

8462

(3001729) Color of Synovial fluid

104

1.27

0.38

1.5

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

142

0.78

0.38

3.4

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.71

0.38

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

124

933

0.92

0.38

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

903

6444

0.97

0.37

5.7

7.5

92.7

93.8

4.99

894

6420

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

179

0.81

0.37

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

550

3956

0.96

0.36

2.3

3.1

46.3

53.7

mg/l

0.54

428

3234

(3034860) Kappa light chains.free [Mass/volume] in Serum

551

3963

0.96

0.36

2.3

3.1

60.7

86.3

mg/l

0.86

425

3234

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

574

4125

0.96

0.36

2.6

0.4

0.3

u/ml

0.27

330

2367

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

160

1189

0.93

0.36

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.62

0.36

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.62

0.36

1.2

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

955

6452

1.03

0.36

5.4

7.5

0.7

4.39

940

6400

(3001964) Herpes simplex virus Ag [Presence] in Specimen

231

0.84

0.36

1.5

1.3

—

(3044941) Cell count panel - Synovial fluid

204

1503

0.94

0.36

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.73

0.36

2.0

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

590

4235

0.97

0.35

1.9

2.3

10.1

10.3

g/l

0.47

435

3480

(3023383) Lactate [Moles/volume] in Pleural fluid

438

1.11

0.34

1.2

1.3

3.8

3.2

mmol/l

0.79

400

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

192

0.83

0.34

1.2

1.1

264.4

283.5

pmol/l

0.12

135

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.69

0.33

6.3

4.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

956

6468

1.03

0.33

5.4

7.4

1.5

1.3

5.95

942

6414

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

369

0.88

0.33

1.8

1.4

5.2

6.2

u/l

1.18

292

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

132

1.21

0.33

1.1

1.2

71.7

114.7

ug/l

0.96

(3024522) Salmonella sp identified in Specimen by Organism specific culture

163

1204

0.94

0.32

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

514

0.90

0.32

1.3

1.4

59.4

68.4

1.03

417

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

126

1.21

0.32

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.35

0.31

1.0

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

581

4158

0.97

0.31

2.0

2.3

3.2

3.1

g/l

0.07

388

3177

(3036670) Protein [Mass/volume] in Synovial fluid

345

0.88

0.31

1.2

39.0

40.1

g/l

0.28

173

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

322

1.12

0.31

1.3

1.4

16.9

20.0

0.42

268

(3032773) Endomysium IgG Ab [Titer] in Serum

512

0.91

0.31

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

263

1.13

0.31

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

375

1.11

0.30

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

114

850

0.93

0.30

1.2

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.28

0.30

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.25

0.30

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

106

0.79

0.29

1.7

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.26

0.28

2.1

2.0

82.1

65.6

—

(3011648) Oxygen content in Venous blood

631

0.92

0.28

1.4

1.7

9.5

10.7

1.89

631

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

213

1.14

0.27

1.3

1.6

0.4

ug/l

0.01

125

(3024263) Appearance of Synovial fluid

498

1.09

0.27

1.4

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

142

928

1.06

0.27

1.3

1.4

12.9

13.6

u/l

0.79

132

886

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

580

0.92

0.27

1.6

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

3164

22189

0.99

0.27

3.7

3.9

80.5

82.6

4.36

3051

21725

(3017569) Oxygen content in Arterial blood

512

1.08

0.27

2.3

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

142

1.17

0.26

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

362

0.90

0.26

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

920

6519

0.98

0.26

1.4

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.25

0.26

1.3

1.6

—

(3003129) Base excess in Capillary blood by calculation

281

0.89

0.25

1.5

2.0

1.4

0.5

mmol/l

0.79

261

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

634

4510

0.97

0.25

2.0

2.3

3.9

3.8

g/l

0.37

385

3116

(3026692) Albumin [Mass/volume] in Peritoneal fluid

237

0.88

0.25

1.3

1.2

13.9

15.5

g/l

0.44

183

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

168

1226

0.95

0.25

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.79

0.24

1.4

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

201

1458

0.96

0.24

1.2

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

422

1.09

0.24

1.0

1.1

2.3

11.1

nmol/l

1.48

(3005988) Vibrio sp identified in Specimen by Organism specific culture

162

1180

0.95

0.23

1.3

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

228

0.88

0.23

5.5

5.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

456

3253

0.97

0.23

1.8

2.3

0.1

g/l

0.06

373

2929

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

1.1

—

0.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

363

1.09

0.22

4.4

6.6

24.6

24.7

mmol/l

0.11

322

(44790047)

137

902

1.05

0.22

1.3

—

(44790049)

137

902

1.05

0.22

1.3

—

(44790048)

137

902

1.05

0.22

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

162

1178

0.95

0.22

1.3

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2089

14327

1.01

0.22

2.3

2.6

20.1

21.2

2.66

1557

12065

(3010144) Erythrocytes [#/volume] in Synovial fluid

126

922

0.95

0.22

1.2

1.4

107223.2

179793.3

e6/l

0.59

642

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.22

0.0

5.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.22

0.0

6.7

—

6.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.22

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.22

0.0

2.7

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

228

1644

0.96

0.22

1.3

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.20

0.21

1.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.76

0.21

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

162

1176

0.96

0.21

1.3

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

175

0.87

0.21

1.3

44.9

75.1

mu/l

0.80

128

(3009015) Lactate [Moles/volume] in Synovial fluid

116

0.84

0.21

1.1

1.2

6.1

6.9

mmol/l

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

204

0.88

0.21

1.4

1.3

23.2

56.0

g/l

0.65

168

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.20

0.0

2.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

637

4514

0.98

0.20

2.0

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

699

0.94

0.20

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

0.82

0.20

1.4

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

638

4518

0.98

0.20

2.0

2.3

7.6

7.5

g/l

0.67

393

3248

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

541

3837

0.98

0.19

2.3

3.1

1.8

4.0

ratio

1.80

274

(44806118)

136

902

1.05

0.18

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

389

0.93

0.18

1.0

290.2

296.7

mg/l

0.25

343

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.21

0.18

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

181

1.11

0.17

1.0

1.2

0.7

1.5

mmol/l

0.84

118

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.13

0.17

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.74

0.17

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

188

1.11

0.17

3.4

2.7

14.9

14.5

ml/dl

0.21

175

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

516

0.94

0.17

3.6

3.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

652

4444

1.02

0.17

2.2

2.4

64.8

28.7

au/ml

—

129

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

563

3982

0.98

0.17

1.2

1.3

46.5

57.3

au/ml

0.45

169

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

531

3757

0.98

0.16

1.9

2.4

1.1

g/l

0.09

400

3138

(3019225) pH of Specimen

1485

10418

0.99

0.16

4.6

4.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

136

983

0.96

0.16

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

387

0.93

0.16

2.2

2.6

40.0

36.6

0.39

142

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.16

0.16

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

224

1602

0.97

0.16

1.6

3.1

4.7

iu/l

2.81

469

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

169

1.11

0.16

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.77

0.16

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

312

2112

1.03

0.15

1.3

1.5

—

(44806071)

1.12

0.15

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.78

0.15

1.6

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

115

831

0.96

0.14

1.2

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

184

0.90

0.14

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

133

0.89

0.14

1.0

1.2

14.4

16.3

u/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.85

0.14

1.0

1.1

1.8

1.7

umol/24h

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

271

1925

0.98

0.13

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

283

0.93

0.13

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

297

0.93

0.13

1.8

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

493

3475

0.98

0.12

1.8

2.2

36.1

36.8

g/l

1.65

359

2895

(3017704) Immunofixation for Urine

647

1.04

0.12

1.3

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

368

1.06

0.12

2.2

2.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

813

5575

1.01

0.12

6.2

8.5

—

(3004775) Volume in Urine collected for unspecified duration

125

895

0.97

0.11

2.0

2.2

665.9

645.9

0.18

577

(44816559) Phosphatidylethanol [Mass/volume] in Blood

106

761

0.97

0.11

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2545

17753

0.99

0.10

1.6

1.7

1.6

mg/l

0.57

1961

13996

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

123

879

0.97

0.10

1.2

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

167

1.08

0.10

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

230

0.94

0.10

1.4

1.5

10.1

9.1

0.05

113

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

237

0.94

0.10

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.08

0.09

1.6

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

101

1.10

0.08

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.82

0.08

2.8

3.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

114

0.91

0.07

1.8

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.09

0.07

1.0

1.2

—

(3035880) pH of Pleural fluid

114

772

1.02

0.07

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

213

0.94

0.07

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

670

0.97

0.07

1.1

1.2

1.1

1.4

nmol/l

3.36

598

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.03

0.07

1.3

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

234

0.95

0.07

2.2

2.6

—

(3046861) Legionella sp Ag [Presence] in Urine

0.87

0.07

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

245

1.05

0.07

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.11

0.06

1.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

100

678

1.02

0.06

1.1

1.2

255.1

212.1

miu/ml

0.23

202

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

212

1452

1.01

0.05

1.2

1.3

0.9

0.8

nmol/l

0.48

160

1198

(3000012) Reticulocyte production index

100

680

1.02

0.05

1.7

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.10

0.05

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

398

1.03

0.05

1.3

778.9

157.8

ug/l

0.65

213

(40761539) Cells [Type] in Urine sediment by Light microscopy

261

1.04

0.04

1.5

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

429

2958

1.01

0.03

2.4

3.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

278

1944

0.99

0.03

1.4

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

205

1409

1.01

0.03

2.0

2.2

32.6

28.5

mg/l

0.35

336

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

226

1555

1.01

0.03

1.1

7.4

12.9

u/ml

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

232

1597

1.01

0.03

2.9

3.2

4.7

4.5

e9/l

0.72

232

1591

(3000285) Sodium [Moles/volume] in Blood

159

0.96

0.02

1.5

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

403

1.02

0.01

1.1

3.1

69.0

73.3

mg/l

0.18

276

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

175

1.03

0.01

1.0

1.2

36.8

425.7

u/l

0.81

122

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

175

1.03

0.01

1.3

79.4

74.5

0.39

149

(3045716) Anion gap in Serum or Plasma

452

1.01

0.01

1.9

2.3

8.7

8.9

mmol/l

0.16

331

(3051611) Lipemic interference index of Serum or Plasma

163

1138

0.99

0.01

3.4

3.6

—

(4212803)

120

1.04

0.01

1.1

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

245

1.02

0.01

1.1

—

(3037756) Immunofixation for Serum or Plasma

373

2582

1.00

0.01

1.3

1.6

—

(44806420)

405

1.01

0.00

2.3

2.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

142

0.98

0.00

1.0

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

237

1.00

0.00

1.3

25.8

30.9

0.37

151

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

237

1.00

0.00

2.9

2.5

7.3

7.8

mmol/l

0.48

159

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

156

0.98

0.00

1.2

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

450

1.00

0.00

3.3

2.9

232.2

221.0

u/l

0.48

445

(3004451) EKG impression Narrative

593

0.99

0.00

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

802

5565

1.00

0.00

1.5

1.7

1.6

g/l

0.68

618

4727

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.02

0.00

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

247

1.01

0.00

1.1

1.2

1.5

mmol/l

0.08

152

(40757494) Bilirubin.total [Moles/volume] in Blood

532

1.00

0.00

2.1

2.0

18.4

34.9

umol/l

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

123

1.02

0.00

1.1

1.3

214.5

190.4

ng/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

232

1.02

0.00

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

156

1.02

0.00

1.7

1.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

50.6

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

88.4

—

(4038314)

0.00

0.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

3.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.0

—

0.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.5

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.5

—

0.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.90

0.00

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.87

0.00

1.2

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_DEMENTIA_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
KRA_PSY_DEMENTIA_EXMORE	2.914 [2.68, 3.17]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 114426 out of 165091 females with KRA_PSY_DEMENTIA_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
KRA_PSY_DEMENTIA_EXMORE	3.312 [2.95, 3.72]	< 0.001
Birth year	0.98 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 70405 out of 98899 males with KRA_PSY_DEMENTIA_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_DEMENTIA_EXMORE.

N-year risk	Females	Males
1	0.177%	0.392%
5	1.081%	2.383%
10	2.531%	6.001%
15	4.733%	10.799%
20	7.806%	17.116%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_DEMENTIA_EXMORE – Any dementia, excluding more controls

GWS hits: 42

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Any dementia, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints